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 9 Zusammenfassung 
1 ZUSAMMENFASSUNG 
1.1 ZIELSETZUNG 
Infektionen mit dem obligat intrazellulären Gram-negativem Bakterium Chlamydia 
trachomatis gehören zu den häufigsten bakteriellen Geschlechtskrankheiten überhaupt; 
darüber hinaus sind sie für meisten verhinderbaren Fälle von Erblindungen, vor allem in 
Entwicklungsländern, verantwortlich. Während die Infektion oft und lange asymptomatisch 
verläuft, kann ein Ausbruch zu entzündlichen Beckenerkrankungen, ektopischen 
Schwangerschaften oder auch Unfruchtbarkeit führen. 
Das Bacterial Ghost-System ist eine Technologieplattform, bei der Gram-negative Bakterien 
mittels Lyse durch das Protein E des Bakteriophagen φX174 ‘entleert’ und getötet werden. 
Die leeren, bakteriellen Hüllen (sogenannte Bacterial Ghosts, abgekürzt BGs) behalten die 
strukturellen, morphologischen und antigenen Eigenschaften ihrer Vorgängerzellen bei. Sie 
können entweder direkt für Vakzinierungen verwendet werden, oder mit aktiven Substanzen 
beladen werden. 
Eine weitere Möglichkeit ist die Verankerung rekombinanter Antigene, die im Rahmen der 
immunstimulierenden Umgebung der BGs präsentiert werden. Dabei kommt den BGs die 
Rolle als natürliches Adjuvans bei. Dies ist besonders ausgeprägt bei Bakterien des 
Escherichia coli Stamms Nissle 1917, der für seine probiotische und immunstimulierende 
Wirkung seit Jahrzehnten verwendet wird. 
Ziel dieser Studie war es daher, BGs auf Basis von E. coli, bevorzugt E. coli Nissle zu 
produzieren, deren Periplasma vor der Lyse mit chlamydialen Antigenen, den 
Vakzinkandidaten PorB und MOMP, befüllt wurde. 
Zu diesem Zweck sollten Plasmide für die Expression und den co-translationalen Export 
dieser beiden Antigene konstruiert werden. Desweiteren sollten unterschiedliche Methoden 
der Induktion der Expression, des Exports in das Periplasma sowie der Markierung und 
Quantifizierung von Antigenen mittels Tags ausgetestet und verglichen werden. Nach 
Experimenten im kleinen Maßstab, in denen zuerst Antigenexpression und anschließend 
Antigenexpression und Lyse getestet wurden, sollten durch Fermentationen in einem 
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Volumen von 20l große Mengen BGs hergestellt werden, deren Periplasma mit chlamydialen 
Antigenen beladen wurde. 
Abschließend soll die Menge chlamydialer Antigene in BGs bestimmt werden. 
1.2 ERGEBNISSE 
Plasmide für die Expression, den Transport ins Periplasma, und die einfache Detektion 
mittels Antikörpern für zwei Chlamydia trachomatis-Antigene, MOMP und PorB, konnten 
erfolgreich kloniert werden. 
Die Expression gefolgt von periplasmatischer Lokalisation von MOMP und PorB wurde 
mittels Western Blot gezeigt. Sie interferiert nicht mit der gleichzeitigen Protein E-
vermittelten Lyse der Bakterien, und Lyse führt zu keinem merklichen Verlust an 
exprimierten chlamydialen Antigenen. 
Bei abschließenden 20l Fermentationen wurden BGs des Stamms E. coli NM522 mit 
periplasmatischem PorB und BGs des Stamms E. coli NM522 mit periplasmatischem MOMP, 
sowie BGs des Stamms E. coli Nissle mit periplasmatischem PorB erzeugt. 
PorB machte dabei etwa ein Fünftel des BG-Trockengewichts aus. In BGs mit MOMP betrug 
dessen Anteil am Trockengewicht etwa ein Drittel; die berechnete Anzahl von PorB-
Molekülen pro BG betrug 2.63∙106 im Fall von E. coli NM522 BGs und 5.08∙106 im Fall von E. 
coli Nissle BGs. Für BGs des Stamms E. coli NM522 wurden 2.19∙107 MOMP Moleküle pro BG 
berechnet. 
Sterile BGs mit den Chlamydia trachomatis-Antigenen PorB und MOMP stehen für weitere 
Versuche bereit, um ihre Immunogenität zu prüfen. 
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2 SUMMARY 
2.1 OBJECTIVES 
Infections with the obligate intracellular Gram-negative bacterium Chlamydia trachomatis 
are a world-wide major healthcare concern. While trachoma is the world’s leading cause of 
preventable blindness (primarily found in developing countries), Chlamydia trachomatis is 
the most common sexually transmitted bacterial pathogen in Western countries. Infection 
often remains asymptomatic, but when they become acute, complications such as Pelvic 
Inflammatory Disease, ectoptic pregnancies and infertility can arise. 
The Bacterial Ghost system is a technology platform with many recognized uses. It utilizes 
protein E of bacteriophage φX174 to lyse and thereby empty and kill Gram-negative 
bacteria, with the remaining empty bacterial envelopes, the so-called ‘Ghosts’, retaining 
their morphological, structural and antigenic characteristics. Bacterial Ghosts (hereafter 
referred to as ‘BGs’) of pathogenic strains can directly be used for vaccination. BGs from 
non-pathogenic strains can be loaded with active substances or DNA for DNA vaccinations. 
Another option is the anchoring of recombinant antigens from other species somewhere in 
the envelope of the BG, taking advantage of its immunostimulatory nature and its capability 
to act as a natural adjuvant. This is especially promising in the case of Escherichia coli Nissle 
1917, a probiotic bacterial strain that has long been recognized as both safe and beneficiary. 
The aim of this project was the production of BGs from E. coli NM522, or (preferentially) E. 
coli Nissle, with their periplasms loaded with the chlamydial vaccine candidate proteins 
MOMP and PorB before the initiation of lysis. 
To achieve these goals, chlamydial antigens were to be cloned into inducible expression 
plasmids with targeting sequences for the export to the periplasm. Furthermore, different 
methods of expression induction, transport to the periplasm and quantification of antigen 
using different tag systems were to be tested and compared. 
After first establishing antigen expression and combined antigen expression and E-mediated 
lysis in small scale experiments, large quantities of BGs with chlamydial antigen-loaded 
periplasms were to be produced by fermentation in a volume of 20l. 
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Subsequently, the amount of chlamydial antigens in BGs was to be quantified. 
2.2 RESULTS 
Plasmids for the expression and the periplasmatic localization of the chlamydial antigens 
PorB and MOMP were successfully cloned. Their correct sequence was first assessed by 
restriction digest pattern analysis, and later shown by the Western Blot detection of tagged 
proteins expressed upon induction in small scale experiments. Protein E-mediated lysis did 
not interfere with protein expression, and vice versa. Lysis did not lead to significant loss of 
protein, indicating the correct localization to the periplasm and the tight sealing of the 
periplasm throughout lysis. 
Large scale fermentation in 20l media produced BGs of the strain E. coli NM522, loaded with 
periplasmatic MOMP and BGs of the strain E. coli NM522, loaded periplasmatic PorB, as well 
as BGs of the strain E. coli Nissle, loaded with periplasmatic PorB. 
Quantification of chlamydial antigens showed that PorB accounted for one fifth of BG mass, 
whereas MOMP constituted one third of its BGs’ mass. The calculated number of PorB 
molecules per individual BG is 2.63∙106 in the case of E. coli NM522 BGs and 5.08∙106 in the 
case of E. coli Nissle BGs. For BGs of E. coli NM522 a total of 2.19∙107 MOMP molecules per 
BG were calculated. 
Sterile BGs, loaded with the chlamydial antigens PorB and MOMP, are available for further 
experiments to assess their immunogenicity. 
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3 INTRODUCTION 
3.1 THE BACTERIAL GHOST PLATFORM TECHNOLOGY 
3.1.1 E-MEDIATED LYSIS OF GRAM-NEGATIVE BACTERIA: 
AN OVERVIEW 
Bacteriophage φX174 of the Microvirus genus preys on Enterobacteriae such as E. coli and 
Salmonella. Virions consist of non-enveloped capsids with icosahedral symmetry, with a 
diameter of 25 – 27nm. The non-segmented, circular ssDNA genome has a length of 5,386bp 
and constitutes 26% of the virion’s weight (Büchen-Osmond, 2006). 
φX174 has been studied extensively; its genome was the first to be sequenced, (Sanger, et 
al., 1977) and the overlapping nature of its genome, resulting in high conservation over time, 
lead to speculations about it being a means of communication by an extraterrestrial society 
(Yokoo, et al., 1979). 
Infection of bacteria with φX174 results in lysis and the release of progeny phage particles; 
lysis requires bacterial growth and is impaired when bacteria are grown on a nutrient-
depleted minimal medium. The lysis protein E is the necessary and sufficient viral factor for 
bacterial lysis (Lubitz, et al., 1984). However, several cellular factors, notably the cell division 
factors FtsZ and FtsA are required for E-lysis, too (Witte, et al., 1998). 
Lysis protein E is a highly hydrophobic, 91aa long structural protein with a mass of 10.5kDa 
and no known enzymatic function. Membrane-bound oligomerization leads to the fusion of 
the inner and the outer membrane, resulting in lysis of the bacteria (Bläsi, et al., 1989). 
The transmembrane tunnel formed by oligomerization of protein E is preferentially located 
at the septum or at polar regions of bacteria; the driving force in cytoplasmic expulsion and 
hence lysis is the osmotic pressure difference between the cytoplasm and the environment 
of the bacteria (Witte, et al., 1992). A transmission electron micrograph of E. coli 
immediately after E-induced lysis, with the transmembrane tunnel indicated, is shown in 
Figure 1. 
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Figure 1: Transmission electron micrograph of E. coli immediately after E-induced lysis. 
Transmembrane tunnel formed by protein E oligomerization is indicated by an arrow. Taken from (Witte, et al., 
1990). 
Lysis leads to the expulsion of cytoplasmic content (including plasmid DNA), to the 
fragmentation of chromosomal DNA and to the breakdown of membrane potential; while 
roughly 90% of the cytoplasmic content is expelled, only 5-10% of the periplasmic content is 
released. The overall structure and morphology of the cell envelope is not affected (Witte, et 
al., 1989). A scanning electron micrograph of the expulsion of cytoplasmic content is shown 
in Figure 2. 
The empty bacterial envelopes with sealed periplasms are called ‘Bacterial Ghosts’, and are 
hereafter referred to as BG (singular) or BGs (plural). 
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Figure 2: High resolution field emission scanning electron micrograph of a Gram-negative bacterium; 
expulsion of cytoplasmic content by E-induced lysis is indicated by an arrow. Taken from (Ebensen, et al., 2004) 
A single lysis tunnel formed by protein E oligomerization is sufficient to lyse bacteria; indeed, 
since lysis takes place in a short time frame (≈1sec), the formation of a second lysis tunnel 
has to take place concomitantly (Witte, et al., 1990). The diameter of the tunnel lies typically 
between 40 – 80nm (Witte, et al., 1990), allowing for the easy passage of virion particles, 
and the expulsion of cytoplasmic components as large as ribosomes (Witte, et al., 1989). 
Since as little as 100 copies of protein E are sufficient for loss of host viability (Maratea, et 
al., 1985) and lysis tunnel formation, tight control and suppression of gene E transcription 
before lysis induction is required (Bläsi, et al., 1985). 
3.1.2 LYSIS PLASMID pGLYSIVB 
For the regulated, inducible formation of BGs the lysis plasmid pGLysivb was developed 
(Haidinger, 2001); a schematic overview of the plasmid is given in Figure 3. 
It is derived from the pBBR1MCS5 variant of plasmid pBBR1 (Szpirer, et al., 2001) and carries 
the bacteriophage φX174 lysis protein E under the regulation of the mutated 
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thermosensitive λpL/pR-cI857 promoter-repressor system. The repressor is active at 
temperatures below 37°C, and full transcriptional activity is reached at 42°C (Jechlinger, et 
al., 1999). 
The plasmid carries a gentamicin resistance cassette. The MOB gene sequence has been 
mutated, with a decreased mobilization activity of 3∙10-2, compared to non-mutated pBBR1 
(Szpirer, et al., 2001). Protein E carries an in vivo biotinylation sequence for easy detection of 
protein E with streptavidin. This increases the molecular weight of Eivb (protein E in vivo 
biotinylated) to 12.7kDa without interfering with lysis ability (Haidinger, 2001). 
 
Figure 3: Schematic representation of plasmid pGLysivb. Indicated are the gentamicin resistance 
cassette (Gent), the mutated mobilization sequence (MOB*), the thermosensitive phage λ repressor system 
(cI857) and the in vivo biotinylated E protein (Eivb). 
3.1.3 POSSIBLE APPLICATIONS 
A wide range of applications for BGs has been proposed and tested, as reviewed in e.g. (Eko, 
et al., 1999) or (Langemann, et al., 2010). These applications include, but are not limited to: 
- direct application of BGs derived from pathogenic bacteria as vaccines, possible for a 
wide range of Gram-negative bacteria 
- usage of recombinant BGs to deliver antigens, either attached to the inner or outer 
membrane, transported to the periplasm or fused to S-layer monomers 
- loading of BGs with active substances, leading to a targeted release in specific cell 
types 
- loading of BGs with DNA, targeted to specific cell types for DNA vaccination 
The retention of the morphological, structural and antigenic features of their living 
precursors, as well as the generation of sealed compartments by the fusion of outer and 
inner membrane, make the BG system an intriguing technology platform, as shown in Figure 
4 (Langemann, et al., 2010). 
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Figure 4: Presentation of antigens in the bacterial envelope/BG. Besides naturally occurring antigens (like LPS, 
flagellae, pili, OMPs and IMPs) acting as adjuvants, a transgenic antigen (TA) can be (1) fused to SbsA or MBP-
SbsA to form a cytoplasmic/periplasmic S-layer; (2) exported to the periplasm fused to MBP; (3) exported to 
the periplasm using a small GIII tag; presented on the Outer Membrane as an OmpA-fusion protein; fused to 
inner membrane proteins like L’, E’, or both; attached via a biotinylation sequence to membrane-bound 
streptavidin; or finally cccDNA carrying a lac operator can be immobilized to the inner membrane, where LacI is 
bound. Taken from (Langemann, et al., 2010) 
BGs have several advantages compared to chemically- or heat-inactivated bacteria: they 
retain their morphological shape and their antigenic features, which are often compromised 
using traditional methods. Furthermore, the loss of cytoplasmic content reduces the risk of 
horizontal gene transfer (Szostak, et al., 1996). 
BGs are taken up efficiently by macrophages and dendritic cells, and actively stimulate 
macrophages and monocytes to induce a TH1-directed immune response. The natural 
adjuvants found on the surface of BGs are recognized and targeted by the innate immune 
system (Haslberger, et al., 2000). 
Furthermore, the production process for BGs is comparatively quick and cheap; lyophilized 
BGs are stable for years at room temperature, which makes the administration as a vaccine 
cold-chain independent (Szostak, et al., 1996). 
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3.2 CHLAMYDIA TRACHOMATIS 
3.2.1 PROPERTIES OF CHLAMYDIA TRACHOMATIS 
In the animal kingdom in general as well as in humans in particular, bacteria of the genus 
Chlamydia are among the most common bacterial pathogens. As non-motile, Gram-negative, 
obligate intracellular bacteria they are distinguished from all other microorganisms by their 
unique developmental cycle. Chlamydia are energy parasites, taking up ATP from their host-
cells without generating it themselves by metabolic reactions (Schachter, 1990). 
Chlamydia replicate in the host cell’s cytoplasm, forming intracellular inclusions observable 
via light microscopy. They exist in two distinct organisational forms, the extracellular 
Elementary Body (EB) and the Reticulate Body (RB) which is formed inside an infected cell 
(Schachter, 1990). 
Chlamydia lack peptidoglycan, both in their EB and RB form (Fox, et al., 1990). The structural 
rigidity of EBs is provided by the cross-linking of three cysteine-rich proteins found in the 
outer membrane, of which the Major Outer Membrane Protein (MOMP) is the most 
important, constituting about 60% of the outer membranes mass (Hatch, et al., 1986). 
EBs are taken up by susceptible host cells via an endocytosis-related process, which is 
enhanced and stimulated by the bacteria. Recent studies have shown that the uptake 
process is likely dependent on clathrin, whereas phagocytosis, caveolae and 
macropinocytosis do not appear to play an important role (Hybiske, et al., 2007). 
Once inside the cell, the fusion of the endosome with phagolysosomes is actively prevented 
by Chlamydia by expressing SNARE-like proteins that block SNARE-mediated membrane 
fusion, protecting the inclusions and the bacteria within them (Paumet, et al., 2009). 
Inside the host cell, the EB reorganizes in the larger, more RNA-rich RB, which is also less 
rigid. This is due to the reduction of the formerly cross-linked outer membrane proteins, 
which also allows MOMP to act as a porin (Bavoil, et al., 1984). Chlamydial cells begin to 
multiply by binary fission as soon as eight hours after the infection, and approximately 18 to 
24 hours after the primary infection, some of the RB reorganize into EB, are released into the 
environment and begin to infect further cells (Schachter, 1990). 
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An overview of the chlamydial lifecycle is given in Figure 5: 
 
Figure 5: Lifecycle of Chlamydia trachomatis. EB – Elementary Bodies. RB – Reticulate Bodies. N – 
Nucleus. Taken from (Mabey, et al., 2003) 
3.2.2 CLINICAL SIGNIFICANCE 
Of the three known species of the Chlamydia genus, C. suis, C. muridarum and C. 
trachomatis, only the latter infects humans. Two other human-pathogenic species of the 
Chlamydiaceae family that were once considered Chlamydia, were recently moved to a new 
genus and are now called Chlamydophila pneumonia and Chlamydophila psittaci (Everett, et 
al., 1999). 
For C. trachomatis, 18 serovars, clustered into two biovars, are known. The 
Lymphogranuloma Venereum biovar consists of serovars L1, L2, L2a and L3, whereas the 
Trachoma biovar consists of serovars A-K plus Ba, Da and Ia and infects superficial columnar 
epithelial cells (Schachter, 1978). 
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Of the 14 Trachoma serovars, A-C are associated with endemic trachoma, the world’s 
leading cause of preventable blindness (Mabey, et al., 2003), whereas serovars D-K are 
primarily associated with sexual infections (Everett, et al., 1999). 
C. trachomatis is the most common sexually-transmitted bacterial pathogen. Even though it 
is treatable with antibiotics, in most cases the genitourinary infection remains asymptomatic 
and hence undetected until major complications arise. These include ectopic pregnancies, 
pelvic inflammatory disease and infertility (Schachter, et al., 1998). 
The need for an effective vaccination against chlamydial infections has lead to a multitude of 
approaches, one of which was the vaccination with inactivated bacteria, which lead to 
severe side-effects due to immunopathogenic components (Brunham, et al., 1994). 
While patients infected with C. trachomatis often develop immunity against re-infection, this 
effect is typically temporarily only; re-infections occurring after waning immunity often lead 
to increased incidences of sequelae, especially infertility (Hillis, et al., 1997). This has at least 
partially been attributed to immunopathogenic complications arising from actions of both 
CD8+ and CD4+ T-lymphocytes, with the former dominating. In contrast, vaccine-induced 
immunity in a murine model is not accompanied by these sequelae upon infection challenge, 
while providing significant levels of protective immunity (Igietseme, et al., 2009). 
The usage of BGs as efficacious vehicles for different chlamydial antigens has been proposed 
using recombinant Vibrio cholera Ghosts (rVCG) (Eko, et al., 2003). These rVCGs induced 
protection from infertility and lead to a significant reduction of infection clearance time in a 
mouse model (Ifere, et al., 2007). 
3.2.3 CHLAMYDIAL ANTIGENS: PORB 
PorB is a 38kDa porin that was first bioinformatically predicted after the C. trachomatis 
genome was sequenced (Stephens, et al., 1998). It is encoded by the porB gene and notably 
conserved among different serovars of C. trachomatis, with only minor or no sequence 
variations, in stark contrast to e.g. MOMP. 
Like MOMP, PorB localizes to the outer membrane, but in much smaller numbers. Its 
transcription and translation coincides with ompA transcription, and PorB is present in both 
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RBs and EBs, throughout the whole developmental cycle. Its surface accessibility to 
antibodies, as well as its function as a porin have been shown experimentally (Kubo, et al., 
2000). 
Human sera from female Chlamydia patients show little or no Anti-PorB-Antibodies, with 
Anti-MOMP-Antibodies dominating. In mice, immunisation with PorB elicits a strong 
antibody response against PorB, especially if mice are subsequently infected with EBs (Kawa, 
et al., 2004). The possibility of neutralizing antibodies against PorB protecting against 
different serovars of C. trachomatis justifies its consideration for vaccine development. 
3.2.4 CHLAMYDIAL ANTIGENS: MOMP 
The Major Outer Membrane Protein, MOMP, of C. trachomatis is encoded by the ompA 
gene, has a mass of 40kDa and constitutes about 60% of the chlamydial outer membrane. In 
its oxidized, cross-linked form the protein is responsible for maintaining the structural 
integrity of the EB, while the reduced form found in RBs is able to act as a porin with an 
upper-size limit of 700Da (Caldwell, et al., 1981). 
MOMP is the key immunogenic antigen of C. trachomatis infections, and antibodies against 
it dominate the humoral response of infected individuals. This evolutionary pressure has 
lead to a plethora of mutations, culminating in MOMP polymorphisms responsible for 18 
different serovariants, which are used to classify C. trachomatis. 
While the five transmembrane β-strands are fundamentally conserved and known as the 
Conserved Domains I-V (CDI – CDV), the four surface-exposed regions are highly variable and 
mutations are clustered here (Variable Domains, VDI – VDIV) (Nunes, et al., 2009). 
The high immunogenicity of MOMP has lead to a focus on this protein for vaccine 
development, but its high variability would necessitate the use of multi-subunit vaccines to 
target the various serovars of C. trachomatis. 
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3.3 ESCHERICHIA COLI NISSLE 1917 
Escherichia coli Nissle 1917 is an E. coli strain first isolated in 1917 by a German physician 
named Nissle, from a soldier who alone among his comrades did not develop 
gastrointestinal diseases (Nissle, 1918). 
E. coli Nissle possesses an H1 flagellum, a K5 capsule and an unusual O6 LPS, with only one 
O6 antigen repeating unit attached to the R1-type core, which contributes to the semi-rough 
morphology of Nissle colonies and is responsible for its serum-sensitivity and hence its safety 
(Grozdanov, et al., 2002). 
E. coli Nissle has been used as a probiotic for over 90 years, meaning that its administration 
in living form in adequate amounts confers health benefits to its host (International Scientific 
Association for Probiotics and Prebiotics, 2009). 
Beside its prophylactic use that has been shown to protect against, amongst others, acute 
and chronic intestine inflammation (Schultz, et al., 2004) and acute secretory diarrhoea 
(Schroeder, et al., 2006), E. coli Nissle has been used therapeutically in Crohn’s Disease and 
Ulcerative Colitis (Schultz, 2008). 
E. coli Nissle has been shown to interact with Peripheral Blood T cells (PBT) via their Toll Like 
Receptor-2 (TLR2), resulting in the downregulation of Interleukin-2 (IL2), Tumor Necrosis 
Factor Alpha (TNF-α) and Interferon Gamma (INFγ) as well as the upregulation of IL-10, 
explaining the beneficial effects on (chronic) intestinal inflammation (Sturm, et al., 2005). 
Furthermore, E. coli Nissle contributes to intestinal immunity by stimulating the production 
of human β–Defensin 2 (Wehkamp, et al., 2004). 
The preferential accumulation of E. coli Nissle in tumour tissue (Stritzker, et al., 2007) has 
lead to speculations about the possibility of using E. coli Nissle expressing apoptin as a 
targeted vehicle for colorectal cancer treatment (Zhou, et al., 2011). 
Additionally, the use of commensal E. coli Nissle in prevention of HIV infection, by having E. 
coli Nissle secrete peptides inhibiting HIV fusion has been discussed (Rao, et al., 2005). 
The recognized safety and the established beneficiary effects of E. coli Nissle make it an 
attractive target for the production of a recombinant BG vaccine. 
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3.4 ADDITIONAL DIAGNOSTIC TOOLS 
3.4.1 LYSIS OBSERVATION VIA FLOW CYTOMETRY 
Once E-lysis is induced, a sharp drop in culture OD600nm is usually observed, which can be 
used as a direct, albeit crude indicator of successful lysis. More reliable data are gathered 
after overnight incubation of count agar plates, which allow the cfu determination before, 
during and after lysis. However, this method is neither able to distinguish between killed 
(dead, intact) and lysed (dead, translucent) cells, nor can it assess killing that takes place 
after the lysis process on the agar plates, during overnight incubation. 
Flow cytometry was used before to assess E lysis and to sort lysed from non-lysed cells 
(displaying Green Fluorescent Protein, GFP) via FACS (Haidinger, et al., 2001). Recently a new 
method was developed to observe E-mediated lysis with a very short time delay (less than 
10min) without the need of GFP expression. 
Two fluorescent dyes are used to distinguish between live intact, dead intact and dead lysed 
cells via flow cytometry: 
- RH414 stains phospholipids indiscriminately, providing a tool with which non-cellular 
background (‘junk’) can be distinguished from biogenic particles. All particles not 
stained by this dye are excluded from the observation. 
- DiBAC4(3) stains only those cells that have lost their membrane potential, i.e. dead 
intact and dead lysed cells.  
By excluding all non-biogenic particles via RH414 and by combining the Forward Scatter 
Signal (FSC) of a particle with its fluorescence signal 1 (FL1) given by DiBAC4(3), three regions 
can be drawn: 
- Region 1 (R1), live intact cells: low FL1 signal (intact membrane potential), high FSC 
(opaque cells) 
- Region 2 (R2), dead intact cells: high FL1 signal (no membrane potential), high FSC 
(intact cells maintaining their opacity) 
- Region 3 (R3), dead lysed cells: medium to high FL1 signal (no membrane potential), 
low FSC (BGs are more translucent than intact cells) 
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Except for a time frame of ≈30min immediately after lysis induction, the live cell counts from 
flow cytometry and the cfu data obtained the next day (after plating) match very closely, 
showing that flow cytometry is an adequate tool for the quasi-live observation of growing, 
possible killing and E-mediated lysis of bacterial cultures (Langemann, et al., 2010). 
3.4.2 PROTEIN QUANTIFICATION USING S-TAG 
The standard method to quantify recombinant proteins in BGs relies on the comparison of 
signal strength from recombinant proteins and a commercially available positope, containing 
several epitopes for commonly used tags (Invitrogen, 2011), in a standardized concentration, 
using Western Blot (Schlacher, 2009). 
Because of the high cost of positope, the time consuming Western Blot procedure, and the 
limited comparability of different-sized proteins due to different blotting efficiencies, a new 
quantification system for recombinant BGs was to be tested. 
The S-Tag system provided by Novagen fuses a 15aa long peptide to recombinant proteins. 
This peptide, known either as S-Peptide or S-Tag, interacts with the S-Protein to form a 
functionally intact RNAse S. 
The native form of RNAse S is called bovine pancreatic RNAse A; the N-terminal α–helix of 
the protein is connected to the globular rest of the structure via a flexible linker; cleaving the 
linker gives rise to the S-Peptide (the N-terminal α–helix) and the S-Protein (the residual 
protein), neither of which is enzymatically active. However, the S-Peptide binds with a very 
high affinity to the S-Protein (KD=10
9M), and functionality is restored. 
This can be used to purify recombinant, S-tagged proteins (with immobilized S-Protein), or 
for quantification: in its intact form, RNAse S cleaves poly(C). A standardized amount of S-
Tag as well as a sample of bacterial culture with recombinant S-tagged proteins is incubated 
with substrate and S-Protein. After the reaction is stopped, the concentration of free 
nucleotides in the supernatant can be measured at A280nm; given an excess of S-Protein and 
substrate, the concentration of free nucleotides is directly proportional to the amount of S-
Tag, and hence of recombinant, S-tagged protein (Novagen, 2009). 
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4 GOALS 
The aims of this work are: 
- to clone the chlamydial antigens MOMP and PorB into expression vectors for export 
into the periplasm 
- to express MOMP and PorB in E. coli NM522 and E. coli Nissle 
- to express MOMP and PorB, followed by E-mediated lysis, generating BGs carrying 
the chlamydial antigens MOMP and PorB, in small scale and large scale experiments 
- to quantify the amount of MOMP and PorB in BGs 
- to test and compare different methods of expression induction (L-arabinose/IPTG), 
transport to the periplasm (fusion to DsbC/GIII) and antigen detection (using Myc/S-
Tags) using the example of PorB 
In order to achieve these goals, a number of plasmids have been designed, as detailed 
below. 
4.1 CLONING STRATEGY pBGKB-PORB 
The pBGKB vector (as seen in Figure 6) is based on Invitrogen’s pBAD-GIII-B vector 
(Invitrogen, 2001), with the ampicillin resistance cassette having been exchanged to a 
kanamycin resistance cassette (Schlacher, 2009). 
The plasmid incorporates a GIII export signal derived from bacteriophage fd, which directs 
proteins to the periplasm using the bacterial Sec transport system; the 18aa signal sequence 
is usually removed after crossing the inner membrane. The export signal is followed by a 
Multiple Cloning Site (MCS), a Myc tag and a C-terminal PolyHis tag. The fusion protein which 
is generated by cloning into the MCS is tightly regulated by the pBAD promoter system. 
Protein expression is turned on by adding L-arabinose and the expression level can simply be 
varied by varying the concentration of L-arabinose (Guzman, et al., 1995). The expression of 
the recombinant protein can be detected (and quantified) using antibodies against either the 
PolyHis or Myc tag. 
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Plasmid pMAL-PorB that served as a template for PCR amplification of porB, was a gift from 
F. Eko (Morehouse School of Medicine, Atlanta, GA, USA) and was constructed by PCR 
amplifying gene porB from Chlamydia trachomatis serovar D and cloning it into vector 
pMAL-p2x (F. Eko, personal communication). Vector pMAL-p2x is commercially available 
(NEB, 2011). 
The cloning strategy for pBGKB-PorB construction is detailed in Figure 6. 
 
Figure 6: Cloning strategy to incorporate PorB into pBGBK, giving rise to pBGKB-PorB 
To effect this cloning, porB is PCR amplified, introducing restriction sites for KpnI and EcoRI, 
giving a PCR fragment of 955bp. Both the PCR product and pBGKB are then digested with 
those restriction enzymes and the fragments are ligated to each other afterwards. 
The primer pair used for PCR amplification is given in Table 1: 
Name Enzyme Direction Sequence (5’ – 3’) Tm 
pBGKB-PorB KpnI Fwd ATATAGGTAC’CATGCCTGCGGGGAATCCG 60°C 
pBGKB-PorB EcoRI Rev ATATAG’AATTCCGAATTGGAATCCTCCGGAGA 60°C 
Table 1:   Primers used to clone PorB into pBGKB 
 27 Goals 
The resultant plasmid pBGKB-PorB has a size of 4979bp; upon induction with L-arabinose, a 
40.8kDa protein in the form of GIII-PorB-Myc-PolyHis is translated and exported to the 
periplasm. When the GIII export sequence is cleaved off, the resultant protein has a size of 
38.7kDa. 
4.2 CLONING STRATEGY pET40B-PORB 
The pET40b vector is available from Novagen (Novagen, 2011) and designed to export 
proteins to the periplasm, fused to the 236aa long DsbC-tag, using the SRP transport system. 
It carries a kanamycin resistance cassette, and the MCS lies between a C-terminal PolyHis tag 
and a 15aa S-Tag. Proteins fused to the S-Tag can interact with the S-Protein to form a 
functionally intact RNAse S. This can be used to quantify proteins in a so called S-Tag assay 
(Novagen, 2011). 
Expression of the fusion protein is induced by activation of T7 RNA Polymerase, which is not 
present on the plasmid, but has to be supplied from the bacterial host strain. The strain E. 
coli C41 which carries an IPTG-inducible T7 RNA polymerase on its chromosome can be used 
for expression experiments with pET40b vector derivates. 
The cloning strategy for pET40b-PorB construction is detailed in Figure 7: 
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Figure 7: Cloning strategy to incorporate PorB into pET40b, giving rise to pET40b-PorB 
To effect this cloning, porB is PCR amplified using pMAL-PorB as a template, introducing 
restriction sites for HindIII and XhoI, giving a PCR fragment of 954bp. These enzymes are 
used to digest the PCR product and pET40b, and the resulting fragments are ligated to each 
other. 
The primer pair used for PCR amplification is given in Table 2: 
Name Enzyme Direction Sequence (5’ – 3’) Tm 
pET40b-PorB HindIII Fwd TATATA’AGCTTATGCCTGCGGGGAATCCG 60°C 
pET40b-PorB XhoI Rev TATATC’TCGAGGAATTGGAATCCTCCGGAGA 60°C 
Table 2:  Primers used to clone PorB into pET40b 
The resultant plasmid pET40b-PorB has a size of 7123bp; upon induction with IPTG, a 
69.1kDa protein in the form of DsBC-PolyHis-S-Tag-PorB-PolyHis is translated and exported 
to the periplasm. While the first 20aa of DsbC, corresponding to the signal sequence for 
periplasmic translocation, are cleaved off by a signal peptidase, the remaining part of DsbC 
stays fused to PorB, in form of a 67.0kDa protein. 
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4.3 CLONING STRATEGY pASK 
To combine the ability of S-Tag quantification with a host-strain independent inducing 
system where the expression level can also be varied by L-arabinose addition, a new 
expression plasmid is constructed and dubbed pASK (plasmid Arabinose-inducible, S-Tagged, 
Kanamycin resistant). Plasmid pASK was designed to export recombinant proteins to the 
periplasm using the GIII export signal; recombinant proteins are tagged with PolyHis and S-
Tags, and their expression can be detected and quantified using Anti-His-Antibodies or S-
Proteins. 
The cloning strategy for pASK construction is outlined in Figure 8: 
 
Figure 8: Cloning strategy for pASK, combining pBGKB’s backbone with pET40b’s MCS and S-Tag 
To effect this cloning, the MCS, S-Tag and one of the His-Tags of pET40b are PCR amplified, 
carrying over the existing SalI restriction site found in the MCS and introducing a BspHI 
restriction site behind the His-Tag, giving a PCR fragment of 200bp. Vector pBGKB is cleaved 
with SalI and StyI (which gives compatible ends to BspHI), the PCR product is cleaved with 
SalI and BspHI, and the fragments are ligated to each other. 
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The primer pair given in Table 3 is used for PCR amplification: 
Name Enzyme Direction Sequence (5’ – 3’) Tm 
pASK BspHI Fwd TATATT’CATGAGTCATCACCATCACCATCACTC 60°C 
pASK SalI Rev TATATG’TCGACGGAGCTCGAATTC 60°C 
Table 3:  Primers used to clone pET40b’s S-Tag, MCS and one of its PolyHis-Tags into pBGKB 
The resultant plasmid pASK has a size of 4142bp; upon induction with L-arabinose, a 10.0kDa 
protein in the form of GIII-PolyHis-S-Tag-PolyHis is translated and exported to the periplasm. 
When the GIII export sequence is cleaved off, the resultant protein has a size of 8.0kDa. 
4.4 CLONING STRATEGY pASK-PORB 
Like pBGKB-PorB, pASK-PorB exports PorB to the periplasm upon arabinose induction, but in 
this case the PorB protein is also S-tagged, in addition to its Myc and PolyHis tag. 
The cloning strategy for pASK-PorB construction is detailed in Figure 9: 
 
Figure 9: Cloning of pASK-PorB by cleaving PorB-Myc out of pBGBK-PorB and ligating it into pASK 
In this case, no PCR amplification is necessary and porB including its Myc tag is cleaved from 
pBGBK-PorB by double digestion with StyI and SalI. The same restriction enzymes are used to 
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digest pASK, effectively removing the entire MCS, and the fragments are ligated to each 
other. 
The resultant plasmid pASK-PorB has a size of 5141bp; upon induction with L-arabinose, a 
46.6kDa protein in the form of GIII-PolyHis-S-Tag-PorB-Myc-PolyHis is translated and 
exported to the periplasm. When the GIII export sequence is cleaved off, the resultant 
protein has a size of 44.6kDa. 
4.5 CLONING STRATEGY pBGKB-MOMP 
The second chlamydial antigen used in this work is the Major Outer Membran Protein, 
MOMP from Chlamydia trachomatis serovar D. It was also a gift from F. Eko, in the form of 
the plasmid pKS-MOMP, which itself is a derivate of plasmid pKSEL5-2, and which has been 
published (Eko, et al., 2003). 
The cloning strategy of pBGKB-MOMP construction is detailed in Figure 10 below: 
 
Figure 10: Cloning strategy to incorporate MOMP into pBGKB, giving rise to pBGKB-MOMP 
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To effect the cloning, ompA is PCR amplified introducing restriction sites for BglII and KpnI, 
giving a PCR fragment of 1133bp. Both the PCR product and pBGKB are then digested with 
those two restriction enzymes, and the fragments are ligated to each other afterwards. 
The primer pair given in Table 4 is used for PCR amplification: 
Name Enzyme Direction Sequence (5’ – 3’) Tm 
pBGKB-MOMP KpnI Fwd TATATGGTAC’CCGAAGCGGAATTGTGCATTTAC 58°C 
pBGKB-MOMP BglII Rev TATATA’GATCTCCTGTGGGGAATCCTGCT 60°C 
Table 4:  Primers used to clone MOMP into pBGKB 
The resultant plasmid pBGKB-MOMP has a size of 5147bp; upon induction with L-arabinose, 
a 46.5kDa protein in the form of GIII-MOMP-Myc-PolyHis is translated and exported to the 
periplasm. When the GIII export sequence is cleaved off, the resultant protein has a size of 
44.4kDa. 
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5 RESULTS 
5.1 CLONING A NEW EXPRESSION PLASMID – pASK 
Midipreps were performed of E. coli C2988J (pET40b) and of E. coli C2988J (pBGKB) to be 
used as source material for this cloning. The MCS, S-Tag and internal His-Tag of pET40b was 
PCR amplified at an annealing temperature of 60°C and an elongation time of 30sec, 
introducing a restriction site for BspHI while carrying over the restriction site of SalI. The 
expected size of the PCR product was 200bp; the PCR product, run on a 2% agarose gel, can 
be seen in Figure 11. 
 
Figure 11: Pfu production PCR, using different amounts of template DNA, of the MCS, S-Tag and internal 
PolyHis tag of pET40b, run on a 2% agarose gel. The correct-sized band can be seen at 200bp. Marker: 
O'GeneRuler™ 50bp DNA Ladder (Fermentas) 
After cleaning up the PCR product with the PCR Purification Kit, two large scale double 
digests were performed for three hours: the PCR product was cut with BspHI and SalI, 
whereas an aliquot of pBGKB was digested with StyI and SalI. 
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Digested DNA was put on an agarose gel, with expected sizes of 190bp for the PCR fragment 
(see Figure 12), and 3940bp for the large fragment of pBGKB (see Figure 13). 
 
Figure 12: PCR product after double-digestion with 
BspHI and SalI, on a 1% agarose gel. The correct sized 
band can be seen at 190bp. Marker: O'GeneRuler™ 
50bp DNA Ladder (Fermentas) 
 
Figure 13: Vector pBGKB after double-digestion with 
StyI and SalI on a 1% agarose gel. The correct-sized 
band is visible at 3940bp. Marker: GeneRuler™ 1kb 
DNA Ladder (Fermentas) 
DNA fragments were excised from the gel and eluted in 50µl dH2O using the Gel Extraction 
Kit. An aliquot of 5µl was put on a 1% agarose gel for concentration determination (not 
shown) and ligation was performed overnight. 
The next day, the ligation mixture was transformed into MOPS-competent E. coli C2988J, 
which were then plated on LB+Kan plates. After overnight incubation at 36°C, plates showed 
good efficiency of transformation. Four clones were picked, inoculated overnight in LBv+Kan 
and miniprepped on the next day. 
Miniprep DNA of different clones was first digested with a single enzyme (not shown), then a 
correct-sized clone was further digested with a total of four different restriction enzymes to 
check for the characteristic, correct pattern of pASK, as seen in Figure 14. 
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Figure 14: Digest of pASK clone A4 on a 1% agarose gel. Lane E1: undigested DNA; Lane R1: pASK 
digested with EcoRI, expected size: 4142bp; Lane R2: pASK digested with HindIII, expected size: 4142bp; Lane 
R3: pASK digested with EcoRV, expected sizes: 1159/2983bp; Lane R4: pASK digested with SmaI, expected sizes: 
1075/3067bp (digest incomplete; repeated digests have found correct pattern). Marker: GeneRuler™ 1kb DNA 
Ladder (Fermentas) 
The correctly-identified clone A4 of E. coli C2988J (pASK) was stored as a glycerol culture and 
later midiprepped for further cloning procedures; since the plasmid was not sequenced, 
confirmation of the correct cloning relies on the restriction digest pattern. 
5.2 CLONING CHLAMYDIAL ANTIGENS 
5.2.1 CLONING pBGKB-PORB 
Midipreps of E. coli C2988J (pBGKB) and E. coli C2988J (pMAL-PorB) were used as source 
material for this cloning. Gene porB was PCR amplified with primers introducing restriction 
sites for KpnI and EcoRI, with an annealing temperature of 60°C and an elongation time of 
60sec. The size of the expected PCR product was 955bp. After the PCR run, the product was 
put on an agarose gel, shown in Figure 15: 
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Figure 15: Pfu production PCR of PorB, using primers introducing XhoI and HindIII restriction sites in 
lanes S1-S7, and using primers introducing KpnI and EcoRI restriction sites in lanes S8-14. The amount of 
template DNA (pMAL-PorB) is indicated under the respective lane. Correct-sized PCR product can be seen at 
954bp (lanes S1-7) and 955bp (lanes S8-14). Samples were run on a 2% gel. Marker: O'GeneRuler™ 50bp DNA 
Ladder (Fermentas) 
After cleaning up the PCR product with the PCR Purification Kit, the PCR product and the 
vector pBGKB were doubly-digested in a large scale restriction digest, using enzymes KpnI 
and EcoRI. After three hours of digestion, fragments were put on an agarose gel, with 
expected sizes of 940bp for the PCR product and 4034bp for the larger vector fragment of 
pBGKB, as seen in Figure 16: 
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Figure 16: PorB PCR product and vector pBGKB after double digestion with KpnI and EcoRI, on a 1% 
agarose gel. Correct-sized bands can be seen at 940bp (PCR product) and 4034bp (pBGKB fragment). Marker: 
GeneRuler™ 1kb DNA Ladder (Fermentas) 
Both fragments were excised from the gel and eluted in 50µl dH2O using the Gel Extraction 
Kit. An aliquot of 5µl was put on a 1% agarose gel for concentration determination (not 
shown), the fragments were ligated to each other overnight and transformed in MOPS-
competent E. coli C2988J cells that were then plated on LB+Kan plates. 
The plates showed good growth after overnight incubation at 36°C; four colonies were 
picked, inoculated in 5ml LBv+Kan overnight and miniprepped on the next day. The four 
clones were first digested with one restriction enzyme to look for the correct size (not 
shown), and a conforming clone was then digested with four enzymes to look for the correct 
digestion pattern of pBGKB-PorB, shown in Figure 17: 
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Figure 17: Digest of pBGKB-PorB clone C1 on a 1% agarose gel. Lane R1: pBGKB-PorB digested with KpnI, 
expected size: 4979bp; Lane R2: pBGKB-PorB digested with BamHI, expected size: 4979bp; Lane R3: pBGKB-
PorB digested with SmaI, expected sizes: 1993/2986bp; Lane R4: pBGKB-PorB digested with HindIII, expected 
sizes: 829/4150bp. Marker: GeneRuler™ 1kb DNA Ladder (Fermentas) 
Restriction digest patterns (not sequencing) were used to identify the correct clone C1 of E. 
coli C2988J (pBGKB-PorB); an aliquote was stored as a glycerol culture and its midiprep DNA 
was used to transform other strains for all further experiments with pBGKB-PorB. 
5.2.2 CLONING pET40B-PORB 
Midipreps of E. coli C2988J (pET40b) and E. coli C2988J (pMAL-PorB) were used as source 
material for this cloning. Gene PorB was PCR amplified with primers introducing restriction 
sites for XhoI and HindIII, with an annealing temperature of 60°C and an elongation time of 
60sec. The size of the expected PCR product was 954bp. After the PCR run, the product was 
put on an agarose gel (see lanes S1-7 of Figure 15). 
After the PCR was cleaned up using the PCR Purification Kit, both the PCR product (see 
Figure 18) and vector pET40b (see Figure 19) were subjected to a large scale double-digest, 
using XhoI and HindIII. After three hours of digestion, the fragments were put on an agarose 
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gel. The expected sizes are 942bp for the PCR fragment and 6175bp for the larger fragment 
of pET40b. 
 
Figure 18: PCR product after double-digestion with 
XhoI and HindIII, on a 1% agarose gel. The correct 
sized band can be seen at 942bp. Marker: 
GeneRuler™ 1kb DNA Ladder (Fermentas) 
 
Figure 19: Vector pET40b after double-digestion with 
XhoI and HindIII, on a 1% agarose gel. The correct 
sized band can be seen at 6175bp. Marker: 
GeneRuler™ 1kb DNA Ladder (Fermentas) 
Correct-sized fragments were excised from the gel and eluted in 50µl dH2O using the Gel 
Extraction Kit; an aliquot of 5µl was put on a 1% agarose gel for concentration determination 
(not shown). Overnight, the fragments were ligated to each other and the ligation product 
was transformed into MOPS-competent E. coli C2988J cells and plated onto LB+Kan plates. 
After overnight incubation at 36°C, plates showed good growth and four colonies were 
picked and inoculated in 5ml LBv+Kan. After overnight inoculation, the four clones were 
miniprepped, and miniprep DNA was digested with one restriction enzyme to find correct-
sized clones (not shown). A correct sized clone was then digested with four different 
restriction enzymes to look for the correct restriction digest pattern of pET40b-PorB, as seen 
in Figure 20: 
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Figure 20: Digest of pET40b-PorB clone B4 on a 1% agarose gel. Lane R1: pET40b-PorB digested with 
DraI, expected size: 7123bp; Lane R2: pET40b-PorB digested with XhoI, expected size: 7123bp; Lane R3: 
pET40b-PorB digested with SmaI, expected sizes: 93/2155/4875bp (smallest band too small to see); Lane R4: 
pET40b-PorB digested with AvaI, expected sizes: 93/910/1245/4875bp (smallest band too small to see). 
Marker: GeneRuler™ 1kb DNA Ladder (Fermentas) 
The correctly-identified clone B4 of E. coli C2988J (pET40b-PorB) was stored as a cryoculture 
and its midiprep DNA was used to transform strain E. coli C41 for further experiments. 
Correctness was assessed by restriction-digest patterns as well as sequencing of regions 
flanking the restriction sides, performed by Microsynth (Microsynth, Balgach, Switzerland). 
Sequencing confirmed the correct insertion (no frameshift) of porB into the pET40b MCS 
(data not shown). 
5.2.3 CLONING pASK-PORB 
Midipreps of E. coli C2988J (pASK) clone A4 and of E. coli C2988J (pBGKB-PorB) clone C1 
were used to perform this cloning; no PCR amplification was necessary. Instead, both vectors 
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were used for a large scale digest with StyI and SalI that linearized pASK and excised PorB 
(including the Myc-tag) from pBGKB-PorB. The expected sizes of the fragments were 4108bp 
for the pASK fragment and 1039/3948bp for the pBGKB-PorB fragments (of which the 
1039bp fragment includes PorB). After three hours of digestion, the fragments were put on 
an agarose gel, shown in Figure 21: 
 
Figure 21: Vectors pASK and pBGKB-PorB after double digestion with StyI and SalI, on a 1% agarose gel. 
Correct-sized bands can be seen at 4108bp (pASK) and 1039/3948bp (pBGKB-PorB). Linearized pASK and the 
PorB fragment at 1039bp were excised and purified for further use. Marker: GeneRuler™ 1kb DNA Ladder 
(Fermentas) 
Correct-sized bands were excised from the gel and eluted in 50µl dH2O using the Gel 
Extraction Kit. An aliquot of 5µl was put on a 1% agarose gel for concentration determination 
(not shown). Overnight, the fragments were ligated to each other and the ligation product 
was transformed into MOPS-competent E. coli C2988J cells and plated onto LB+Kan plates. 
After overnight incubation at 36°C, plates showed good growth and four colonies were 
picked and inoculated in 5ml LBv+Kan. After overnight inoculation, the four clones were 
miniprepped, and miniprep DNA was digested with one restriction enzyme to find correct-
sized clones (not shown). A correct sized clone was then digested with three different 
restriction enzymes to check the correct restriction digest pattern of pASK-PorB. This can be 
seen in Figure 22: 
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Figure 22: Digest of pASK-PorB clone A3 on a 1% agarose gel. Lane R1: pASK-PorB digested with XbaI, 
expected size: 5141bp; Lane R2: pASK-PorB digested with XhoI, expected sizes: 2321/2820bp; Lane R3: pASK-
PorB digested with HindIII, expected sizes: 829/4312bp. Marker: GeneRuler™ 1kb DNA Ladder (Fermentas) 
The correctly-identified clone A3 of E. coli C2988J (pASK-PorB) was stored as a glycerol 
culture; its midiprep DNA was used to transform other strains for all further experiments 
with pASK-PorB. The identification relied on restriction-digest pattern analysis, and not 
sequencing. 
5.2.4 CLONING pBGKB-MOMP 
Midipreps of E. coli C2988J (pBGKB) and E. coli C2988J (pKS-MOMP) were used as source 
material for this cloning. Gene MOMP was PCR amplified with primers introducing restriction 
sites for KpnI and BglII, with an annealing temperature of 58°C and an elongation time of 
60sec. The size of the expected PCR product was 1133bp. After the PCR run, the product was 
put on an agarose gel, shown in Figure 23: 
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Figure 23: Pfu production PCR of MOMP, using primers introducing KpnI and BglII restriction sites. The 
amount of template DNA (pKS-MOMP) is indicated under the respective lane. Correct-sized PCR product can be 
seen at 1133bp. Samples were run on a 1% agarose gel. Marker: GeneRuler™ 1kb DNA Ladder (Fermentas) 
After cleaning up the PCR product with the PCR Purification Kit, the PCR product and the 
vector pBGKB were doubly-digested in a large scale restriction digest, using enzymes KpnI 
and BglII. After three hours of digestion, fragments were put on an agarose gel, with 
expected sizes of 1117bp for the PCR product and 4026bp for the larger fragment of pBGKB; 
the gel picture can be seen in Figure 24: 
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Figure 24: Vector pBGKB and PCR product of MOMP after double digestion with KpnI and BglII, on a 1% 
agarose gel. Correct-sized bands can be seen at 4026bp (pBGKB) and 1117bp (PCR Product MOMP). Marker: 
GeneRuler™ 1kb DNA Ladder (Fermentas) 
Correct-sized bands were excised from the gel and eluted in 50µl dH2O using the Gel 
Extraction Kit. An aliquot of 5µl was put on a 1% agarose gel for concentration determination 
(not shown). Fragments were ligated to each other overnight and the ligation product was 
transformed into MOPS-competent E. coli C2988J cells and plated onto LB+Kan plates. After 
overnight incubation at 36°C, plates showed good growth and twenty colonies were picked 
and inoculated in 5ml LBv+Kan. After overnight inoculation, the twenty clones were 
miniprepped, and miniprep DNA was digested with one restriction enzyme to find correct-
sized clones (not shown). A correct sized clone was then digested with four different 
restriction enzymes to look for the correct restriction digest pattern of pBGKB-MOMP, 
shown in Figure 25: 
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Figure 25: Digest of pBGKB-MOMP clone A11 on a 1% agarose gel. Lane R1: pBGKB-MOMP digested with 
EcoRV, expected sizes: 1371/3776bp; Lane R2: pBGKB-MOMP digested with HindIII, expected sizes: 
315/829/4003bp (the smallest band is too small to be seen); Lane R3: pBGKB-MOMP digested with KpnI, 
expected size: 5147bp; Lane R4: pBGKB-MOMP digested with XhoI, expected sizes: 818/1671/2658bp. Marker: 
GeneRuler™ 1kb DNA Ladder (Fermentas) 
The correctly-identified clone A11 of E. coli C2988J (pBGKB-MOMP) was stored as a glycerol 
culture; its midiprep DNA was used to transform other strains for all further experiments 
with pBGKB-MOMP; identification relied on restriction-digest pattern analysis, and not 
sequencing. 
5.3 EXPRESSING CHLAMYDIAL ANTIGENS 
All of the following small scale experiments were carried out in E. coli C2988J, except for the 
expression experiment of pET40b-PorB, which requires the chromosomal T7 RNA 
Polymerase of E. coli C41. While the growth rate of E. coli C2988J is lower than of E. coli 
NM522 (the preferred strain for antigen expression for BG production), this is not relevant 
for the simple determination whether antigen is expressed using the cloned plasmids. 
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5.3.1 EXPRESSION STUDY pBGKB-PORB 
In this small scale expression experiment, two noseflasks (1 and 2) were inoculated with 
overnight culture of the backbone plasmid carrying E. coli C2988J (pBGKB) and two 
noseflasks (3 and 4) where inoculated with overnight culture of clone C1 of E. coli C2988J 
(pBGKB-PorB). 
All four noseflasks were grown at 36°C until an OD600nm≈0.3, when expression was induced in 
noseflasks 2 and 4 by adding 0.2% L-arabinose (time point 0min). OD values were measured 
and samples were collected for WB and cfu determination throughout the experiment; 
plates for cfu counting were incubated at 36°C overnight. A graph showing OD600nm and cfu 
values for all four noseflasks is given in Figure 26. 
 
Figure 26: OD and cfu values over time during an expression experiment of E. coli C2988J (pBGKB) (flasks 
1 and 2) and E. coli C2988J (pBGKB-PorB) (flasks 3 and 4). L-Arabinose was added at time point 0min to flasks 2 
and 4. 
While the OD values of all four flasks behave similarly, the induction of pBGKB-PorB (but not 
pBGKB) leads to a decrease in cfu of roughly 40% 60min after expression induction, which is 
not seen after 30min of expression, suggesting the mild toxicity of PorB when exported to 
the periplasm. 
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Western Blot samples just prior to L-arabinose induction and after 60min of protein 
expression were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was blotted 
onto nitrocellulose, the nitrocellulose incubated with HRP-coupled-Anti-Myc-antibodies and 
developed by chemiluminiscence; the protein GIII-PorB-Myc-PolyHis was expected at a size 
of 40.8kDa, protein PorB-Myc-PolyHis, lacking the GIII export sequence, at a size of 38.7kDa. 
The developed Western Blot is shown in Figure 27. 
 
Figure 27: Western Blot of E. coli C2988J (pBGKB-PorB) Expression Experiment, using Unstained Protein 
Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES Running 
Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-antibodies and developed. Samples A are at the time point of expression induction, samples 
C are 60min later. Expression was induced in flasks 2 and 4. 
The Western Blot shows the correct-sized signal only upon induction and only in samples 
where plasmid pBGKB-PorB was present (C4); hence it can be concluded that PorB can 
successfully be expressed from plasmid pBGKB-PorB upon induction. 
5.3.2 EXPRESSION STUDY pET40B-PORB 
Since the expression system of the pET40b vector system relies on T7 RNA polymerase, 
plasmid pET40b-PorB was transformed into MOPS-competent E. coli C41 cells. For the small 
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scale expression experiment, two noseflasks (1 and 2) were inoculated with the empty 
backbone plasmid carrying E. coli C41 (pET40b) whereas two noseflasks (3 and 4) were 
inoculated with clone A1 of E. coli C41 (pET40b-PorB). After growing at 36°C to an 
OD600nm≈0.35, expression was induced in noseflasks 2 and 4 by adding 1mM IPTG (at time 
point 0min). OD600nm values were measured and samples for WB and cfu determination were 
collected throughout the experiment; plates for cfu counting were incubated at 36°C 
overnight. OD600nm and cfu values of this experiment, plotted over time are shown in Figure 
28. 
 
Figure 28: OD and cfu values over time during an expression experiment of E. coli C41 (pET40b) (flasks 1 
and 2) and E. coli C41 (pET40b-PorB) (flasks 3 and 4). IPTG was added at time point 0min to flasks 2 and 4. 
The overall picture is quite similar to the expression experiment of pBGKB-PorB: while the 
OD values of all four flasks behave similarly, the induction of pET40b-PorB (but not pET40b) 
leads to a strong decrease in cfu (almost 98%) 180min after expression induction, compared 
to the value before induction. This cfu decrease is apparent after 60min of expression, 
becoming more dramatic over time, but is not detected 30min after expression induction. 
Western Blot samples just prior to IPTG induction and after 60min of protein expression 
were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto 
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nitrocellulose, the nitrocellulose incubated with S-Protein-HRP and developed by 
chemiluminiscence; the protein DsbC-PolyHis-S-Tag-PorB-PolyHis was expected at a size of 
69.1kDa (67kDa for DsbC-PolyHis-S-Tag-PorB-PolyHis with the signal sequence of DsbC 
cleaved off). The developed WB is shown in Figure 29. 
 
Figure 29: Western Blot of E. coli C41 (pET40b-PorB) Expression Experiment, using Unstained Protein 
Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES Running 
Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:10,000 diluted S-
Protein-HRP and developed. Samples A are at the time point of expression induction, samples C are 60min 
later. Expression was induced in flasks 2 and 4. 
Unfortunately, the Western Blot fails to detect a specific signal associated with PorB, even 
though the cfu values of flask 4 show a similar trend as in the experiment with pBGKB-PorB, 
where PorB is also expressed. 
While the background signal is fairly high, a distinct and unique band can be seen in lane C2, 
corresponding to the expressed product of the empty backbone vector, DsbC-PolyHis-S-Tag-
PolyHis at 34.7kDa. This shows the ability of the HRP-coupled S-Protein to bind to the S-Tag, 
which makes the absence of signal in lane C4 even more conspicuous. Anyhow, since the 
backbone expression is very weak (compared to the background signal) a problem with the 
WB development can be assumed. 
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Therefore, a second Western Blot (not shown) with a similar loading scheme was performed 
and incubated with HRP-coupled-Anti-His-antibodies, showing the same result – very weak 
recognition of DsbC-PolyHis-S-Tag-PolyHis, but no detection of a PorB protein and a high 
background signal. 
No further work with this plasmid was performed. 
5.3.3 EXPRESSION STUDY pASK 
In order to test whether the expression of GIII-PolyHis-S-Tag-PolyHis (the gene product 
encoded by the newly cloned backbone vector pASK) has any influence on the viability of 
bacteria, a small scale expression experiment was carried out. 
Two noseflasks (1 and 2) were inoculated with overnight culture of clone A4 of E. coli C2988J 
(pASK). Both noseflasks were grown at 36°C until an OD600nm≈0.35, when expression was 
induced in noseflask 1 by adding 0.2% L-arabinose (at time point 0min). OD values were 
measured and samples for WB and cfu determination were collected throughout the 
experiment; plates for cfu counting were incubated at 36°C overnight. OD600nm and cfu 
values over time are shown in Figure 30. 
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Figure 30: OD and cfu values over time during an expression experiment of E. coli C2988J (pASK). L-
Arabinose was added at time point 0min to flask 1. 
No significant difference in OD600nm or cfu values could be observed, indicating that the 
newly cloned expression plasmid pASK per se is not harmful to bacterial growth when 
expression is induced. 
Since the of GIII-PolyHis-S-Tag-PolyHis and PolyHis-S-Tag-PolyHis are only 10.0kDa and 
8.0kDa, respectively, no Western Blot was performed to detect the expression product of 
pASK. However, a quantification using the S-Tag system was performed, as described in 
Chapter 5.6.4 Quantification of Recombinant Proteins Using the S-Tag System and in detail in 
Figure 64. 
5.3.4 EXPRESSION STUDY pASK-PORB 
In this small scale expression experiment, two noseflasks (1 and 2) were inoculated with 
overnight culture of clone A3 of E. coli C2988J (pASK-PorB). Both noseflasks were grown at 
36°C until an OD600nm≈0.35, when expression was induced in noseflask 1 by adding 0.2% L-
arabinose (at time point 0min). OD values were measured and samples for WB and cfu 
determination were collected throughout the experiment; plates for cfu counting were 
incubated at 36°C overnight. OD600nm and cfu values over time are shown in Figure 31. 
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Figure 31: OD and cfu values over time during an expression experiment of E. coli C2988J (pASK-PorB). L-
Arabinose was added at time point 0min to flask 1. 
Similar to previous expression experiments of PorB (in different vector systems), induction of 
PorB expression leads to a decrease of viability in comparison to a non-induced sample. 
Interestingly the effect seen in pASK-PorB is smaller than in either pBGKB-PorB or pET40b-
PorB, and after 120min of expression, the cfu is still higher than it was at the induction point 
(in contrast to previous experiments). As before, OD values behave nearly identical on both 
samples, regardless to induction. 
Western Blot samples just prior to L-arabinose induction, after 20min, 60min and 120min of 
protein expression were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was 
blotted onto nitrocellulose, the nitrocellulose incubated with S-Protein-HRP and developed 
by chemilumiscence; the protein GIII-PolyHis-S-Tag-PorB-Myc-PolyHis was expected at a size 
of 46.6kDa, and the protein PolyHis-S-Tag-PorB-Myc-PolyHis (lacking the GIII export 
sequence) at a size of 44.6kDa. The developed blot is shown in Figure 32. 
 53 Results 
 
Figure 32: Western Blot of C2988J + pASK-PorB Expression Experiment, using Unstained Protein 
Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES Running 
Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 diluted S-Protein-
HRP and developed. Samples are at 0min (B), 20min (C), 60min (E) and 120min (F) of protein expression after 
induction. As a positive control, a sample from a C41 + pET40b expression experiment was used. Expression 
was induced in flask 1. 
Again, the background signal is fairly high. The specific signals detected by the HRP-coupled-
S-Protein are the positive control of DsbC-PolyHis-S-Tag-PolyHis, and the S-Tagged PorB 
protein of induced pASK-PorB. Signal can first be detected after 60min (but not 20min) of 
expression in sample E1, and again after 120min (F1). 
5.3.5 EXPRESSION STUDY pBGKB-MOMP 
In this small scale expression experiment, two noseflasks (1 and 2) were inoculated with 
overnight culture of clone A11 of E. coli C2988J (pBGKB-MOMP). Both noseflasks were grown 
at 36°C until an OD600nm≈0.35, when expression was induced in noseflask 1 by adding 0.2% L-
arabinose (at time point 0min). OD values were measured and samples for WB and cfu 
determination were collected throughout the experiment; plates for cfu counting were 
incubated at 36°C overnight. OD600nm and cfu values are plotted against time in Figure 33. 
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Figure 33: OD and cfu values over time during an expression experiment of E. coli C2988J (pBGKB-
MOMP). L-Arabinose was added at time point 0min to flask 1. 
As seen with PorB, the expression and export of MOMP to the periplasm seems to have a 
toxic effect on bacteria, with a cfu decline of 97% 90min after expression induction, in 
comparison to the cfu at the start of the expression. Just like in other experiments, OD 
values behave nearly identical regardless to induction. The cfu decrease is first apparent 
60min after expression induction, becoming more dramatic over time, but is not detected 
30min after expression induction. 
Western Blot samples just prior to L-arabinose induction, after 30min, 60min and 90min of 
protein expression were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was 
blotted onto nitrocellulose, the nitrocellulose incubated with HRP-coupled-Anti-Myc-
Antibody and developed by chemiluminiscence; the protein GIII-MOMP-Myc-PolyHis was 
expected at a size of 46.5kDa, while protein MOMP-Myc-PolyHis (with the GIII signal 
sequence removed) was expected at a size of 44.4kDa. The developed blot is shown in Figure 
34. 
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Figure 34: Western Blot of E. coli C2988J (pBGKB-MOMP) Expression Experiment, using Unstained 
Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 diluted 
HRP-coupled Anti-Myc-antibodies and developed. Samples were taken 0min (B), 30min (C), 60min (D) and 
90min (E) after expression induction. Expression was induced in flask1. As a positive control, an induced sample 
of pBGKB-PorB has been used. 
Expressed MOMP can successfully be detected first 30min after expression induction, and 
strongly after 60min and 90min, at the expected size. No signal at the correct size can be 
seen without induction. 
5.4 SMALL SCALE EXPRESSION/LYSIS EXPERIMENTS 
After the successful expression of the chlamydial antigens from plasmids pBGKB-PorB, pASK-
PorB and pBGKB-MOMP had been shown, those plasmids were to be co-transformed with 
the E-lysis plasmid pGLysivb into E. coli NM522 and into E. coli Nissle, since those two strains 
yield higher growth rates and are the preferable strains for in vivo immunization trials. 
Small scale expression/lysis experiments attempted to show that it was possible to: 
- first express and export chlamydial antigens to the periplasm, 
- to induce lysis afterwards, and 
- to retain the antigens in the BGs. 
Representative expression/lysis curves are shown in the following chapters. 
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5.4.1 EXPRESSION/LYSIS OF pBGKB-PORB IN E. COLI 
NM522 
The goal of this first small scale expression/lysis experiment was to determine the optimal 
time of expression before lysis induction in regards to lysis efficiency and expression yield. 
Two noseflasks (1 and 2) were inoculated with a clone of E. coli NM522 (pBGKB-PorB, 
pGLysivb). 
After reaching an OD600nm≈0.3, 0.2% L-arabinose was added to all three flasks. In flask 1, lysis 
was induced by temperature shifting to 42°C after 30min of expression, whereas in flask 2 
this was done after 60min (time point 0min for both cases). 
OD600nm values were measured and samples were collected for WB and cfu determination 
throughout the experiment; plates for cfu counting were incubated at 36°C overnight. 
OD600nm and cfu values are plotted against time in Figure 35. 
 
Figure 35: OD and cfu values over time during an expression/lysis experiment of E. coli NM522 (pBGKB-
PorB, pGLysivb). L-Arabinose was added at time point -30min to flask 1, and time point -60min to flask 2. Lysis 
was induced by shifting to 42°C at time point 0min. 
After expression induction with L-Arabinose, OD600nm increases in both flasks until lysis 
induction at time point 0min, whereas cfu values increase only in flask 1 up until lysis 
 57 Results 
induction, while in flask 2 cfu values start to drop after 45min of expression, even before 
lysis induction at time point 0min. While the cfu decreases in both flasks, it does less so in 
flask 2, where lysis was preceded by 60min of expression. While flask 1 has a lysis efficiency 
of 99.86% from time point 0min to time point 120min (as determined by cfu counting), lysis 
efficiency of flask 2 is only at 97.70% percent in the same time frame, indicating interference 
of prolonged PorB expression with successful lysis. Additionally, killing is also apparent 
before lysis induction in flask 2, whereas cfu still increases during the expression time of 
PorB in flask 1. Indeed, PorB expression seems to become toxic between 30min and 45min 
of expression, just about the time lysis becomes effective as well in flask 1, where lysis is 
induced after 30min of expression. 
Western Blot samples just prior to L-arabinose induction, after 60min and after 120’ of 
protein expression were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was 
blotted onto nitrocellulose, the membrane incubated with HRP-coupled-Anti-Myc-
Antibodies and developed by chemiluminiscence, as seen in Figure 36. Protein GIII-PorB-
Myc-PolyHis was expected at a size of 40.8kDa, protein PorB-Myc-PolyHis at a size of 
38.7kDa. 
 58 Bacterial Ghosts Displaying Chlamydia trachomatis Antigens 
 
Figure 36: Western Blot of E. coli NM522 (pBGKB-PorB, pGLysivb) Expression/Lysis Experiment, using 
Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with 
MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 
diluted HRP-coupled Anti-Myc-Antibodies and developed. Samples B are at the time point of expression 
induction, samples E are 60min later – after 30min of lysis for samples 1 and 3, and just before lysis induction 
sample 2. Samples G are 120min after expression induction, after 90min of lysis for 1 and 3, and 60min of lysis 
for 2. Samples 3 are E. coli NM522 (pBGKB, pGLysivb), and are used as an expression-negative control. 
The expression of PorB can be seen in induced samples with no visible background 
expression. Only a slight decrease over time was detected (compare sample E1 with sample 
G1) which could be due to protein degradation or due to loss of expressed protein that was 
not exported to the periplasm before E-lysis. Because of higher lysis efficiency for shorter 
expression time and less killing by recombinant protein, future experiments will use an 
expression time of 30min before lysis induction. 
5.4.2 EXPRESSION/LYSIS OF pBGKB-PORB IN E. COLI NISSLE 
E. coli Nissle was co-transformed with plasmids pBGKB-PorB and the E-lysis plasmid 
pGLysivb, at very low transformation efficiencies. In a small scale expression/lysis 
experiment, the successful expression and export to the periplasm of PorB followed by E-
 59 Results 
lysis was to be shown. As a lysis negative control, E. coli Nissle was also co-transformed with 
pBGKB-PorB and pBBR1MCS5 (the backbone plasmid of pGLysivb). 
One noseflask (sample 1) was inoculated with a clone of E. coli Nissle (pBGKB-PorB, 
pGLysivb), while a second noseflask (sample 2) was inoculated with E. coli Nissle (pBGKB-
PorB, pBBR1MCS5). 
After reaching an OD600nm≈0.3, 0.2% L-arabinose was added to both flasks. After 30min of 
expression, both flasks were shifted to 42°C, activating the thermosensitive promoter of 
pGLysivb (time point 0min). 
OD600nm values were measured and samples for WB and cfu determination were collected 
throughout the experiment; plates for cfu counting were incubated at 36°C overnight. 
OD600nm and cfu values are plotted against time in Figure 37. 
 
Figure 37: OD and cfu values over time during an expression/lysis experiment of E. coli Nissle (pBGKB-
PorB, pGLysivb), with E. coli Nissle (pBGKB-PorB, pBBR1MCS5) used as a lysis negative control. L-Arabinose was 
added at time point -30min to flasks 1 and 2; lysis was induced by shifting to 42°C at time point 0min. 
In both samples cfu values rise until the temperature shift to 42°C, after which they drop 
rapidly for sample 1, indicating successful E-lysis, and stagnate for sample 2, indicating the 
toxic effects of prolonged PorB expression and export to the periplasm. OD600nm values 
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continue to rise for sample 2, and drop for sample 1 after the temperature shift. The lysis 
efficiency for E. coli Nissle (pBGKB-PorB, pGLysivb) is 99.80%, as determined by cfu counting. 
Western Blot samples just prior to L-arabinose induction, just prior to lysis induction and 
after 40min and 90min of lysis were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The 
gel was blotted onto nitrocellulose, the membrane incubated with HRP-coupled-Anti-Myc-
Antibodies and developed by chemiluminiscence, as seen in Figure 38. Protein GIII-PorB-
Myc-PolyHis was expected at a size of 40.8kDa, and protein PorB-Myc-PolyHis at a size of 
38.7kDa. 
 
Figure 38: Western Blot of E. coli Nissle (pBGKB-PorB, pGLysivb) Expression/Lysis Experiment, using 
Unstained Protein Molecular Weight Marker (Fermentas). As a positive control, a PorB sample from an E. coli 
NM522 (pBGBK-PorB, pGLysivb) Expression/Lysis Experiment was used. Proteins were separated on a 4-12% 
Bis-Tris-Gel with MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated 
with 1:5000 diluted HRP-coupled Anti-Myc-Antibodies and developed. Samples B are at the time point of 
expression induction, samples C at the time point of lysis induction. 
The signal of Myc-tagged PorB can first be seen 30min after expression induction at the 
correct-size. Signal is strongest after 70min of expression/40min of lysis in flask 1 and while 
the signal somewhat diminishes with time, it does so in both the samples where lysis was 
induced (samples 1) and where no lysis took place (samples 2). Therefore, this slight signal 
decrease is most likely due to protein degradation, and not due to loss during the E-lysis 
process. 
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5.4.3 EXPRESSION/LYSIS OF pASK-PORB IN E. COLI NM522 
After the successful co-transformation of pASK-PorB (as well as pASK as an expression-
negative backbone plasmid) and pGLysivb into E. coli NM522, two noseflasks were 
inoculated with E. coli NM522 (pASK, pGLysivb) overnight culture (samples 1 and 2) and two 
other noseflasks (samples 3 and 4) were inoculated with E. coli NM522 (pASK-PorB, 
pGLysivb); all four noseflasks were incubated in a water bath at 36°C 
After reaching an OD600nm≈0.3, 0.2% L-arabinose was added to all four flasks. After 30min of 
expression, flasks 2 and 4 were shifted to 42°C, inducing lysis at time point 0min. 
OD600nm values were measured and samples for WB and cfu determination were collected 
throughout the experiment; plates for cfu counting were incubated at 36°C overnight. 
OD600nm and cfu values are plotted against time in Figure 39. 
 
Figure 39: OD and cfu values over time during an expression/lysis experiment of E. coli NM522 (pASK-
PorB, pGLysivb), with E. coli NM522 (pASK, pGLysivb) used as an expression negative control. L-Arabinose was 
added at time point -30min to all four flasks; lysis was induced by shifting flasks 2 and 4 to 42°C at time point 
0min. 
Whereas the induction of pASK and pASK-PorB without lysis induction leads to cfu 
stagnation (samples 1 and 3), combination of expression induction and lysis induction 
(samples 2 and 4) leads to strong decrease of cfu after temperature shift to 42°C, with 
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calculated lysis efficiencies (from cfu counting) of 99.97% for E. coli NM522 (pASK-PorB, 
pGLysivb) and of 99.90% for E. coli NM522 (pASK, pGlysivb). 
Western Blot samples just prior to lysis induction and after 60min of lysis (in flasks 2 and 4) 
were separated on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto 
nitrocellulose, the membrane incubated with HRP-coupled S-Protein and developed by 
chemiluminiscence, as seen in Figure 40. Protein GIII-PolyHis-S-Tag-PorB-Myc-PolyHis was 
expected at a size of 46.6kDa, and protein PolyHis-S-Tag-PorB-Myc-PolyHis at a size of 
44.6kDa. 
 
Figure 40: Western Blot of E. coli NM522 (pASK-PorB, pGLysivb) Expression/Lysis Experiment, using 
Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with 
MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5,000 
diluted S-Protein-HRP and developed. Samples are at 30min (B) and 90min (E) of protein expression. As a 
positive control, a sample from an E. coli C41 (pET40b) Expression Experiment was used. Expression was 
induced in all flasks, whereas lysis was induced only in flasks 2 and 4. 
While the background signal is again very high, S-tagged PorB is recognized 90min after 
induction in both samples carrying pASK-PorB, regardless whether they underwent lysis or 
not. No signal is visible after 30min of expression in either sample. Expulsion of cytoplasmic 
content during E-lysis is evident by the strongly diminished background signal in samples E2 
and E4 (where lysis was induced). 
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5.4.4 EXPRESSION/LYSIS OF pBGKB-MOMP IN E. COLI 
NM522 
After the successful co-transformation of pBGKB-MOMP and pGLysivb into E. coli NM522, 
four noseflasks were inoculated with overnight cultures of four different clones and grown 
at 36°C. 
After reaching an OD600nm≈0.3, 0.2% L-arabinose was added to all four flasks. After 30min of 
expression, all flasks were shifted to 42°C, inducing lysis at time point 0min. 
OD600nm values were measured and samples for WB and cfu determination were collected 
throughout the experiment; plates for cfu counting were incubated at 36°C overnight. 
OD600nm and cfu values are plotted against time in Figure 41. 
 
Figure 41: OD and cfu values over time during an Expression/Lysis Experiment of four different clones of 
E. coli NM522 (pBGKB-MOMP, pGLysivb). L-Arabinose was added at time point -30min; lysis was induced by 
shifting all four flasks to 42°C at time point 0min. 
All four clones show similar OD600nm and cfu behaviour; while cfu increases after induction of 
MOMP expression at time point -30min and until lysis induction at time point 0min, it drops 
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sharply afterwards, with lysis efficiencies between 99.79% (clone 4) and 99.97% (clone 1), as 
calculated by cfu counting. 
Western Blot samples just prior to lysis induction and after 60min of lysis were separated on 
two identical 4-12%-Bis-Tris-Gels with MES buffer. The gels were blotted onto nitrocellulose; 
one of the membranes incubated with HRP-coupled-Anti-Myc-Antibodies (see Figure 42), 
the second first with Goat-Anti-MOMP-Antibody and then with HRP-coupled-Anti-Goat-
Antibodies (see Figure 43), and developed by chemilumiscence. Protein GIII-MOMP-Myc-
PolyHis was expected at a size of 46.5kDa, protein MOMP-Myc-PolyHis at a size of 44.4kDa. 
 
Figure 42: Western Blot of E. coli NM522 (pBGKB-MOMP, pGLysivb) Expression/Lysis experiment with 
four different clones, using Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated 
on a 4-12% Bis-Tris-Gel with MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose 
was incubated with 1:5000 diluted HRP-coupled Anti-Myc-Antibodies and developed. Samples were taken 0min 
(B) and 60min (E) after lysis induction. As a positive control, an induced sample of an E. coli C2988J (pBGKB-
MOMP) Expression Experiment was used. 
Myc-tagged MOMP can be detected in all samples at the correct size; while the 
concentration varies considerably 30min after expression induction, after 60min of lysis the 
amount of MOMP is roughly equal in all clones, with a slightly stronger signal for flask 1. 
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Figure 43: Western Blot of E. coli NM522 (pBGKB-MOMP, pGLysivb) Expression/Lysis experiment with 
four different clones, using Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated 
on a 4-12% Bis-Tris-Gel with MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose 
was incubated with 1:500 diluted Goat-Anti-MOMP-Antibodies and with 1:5000 diluted HRP-coupled-Anti-
Goat-Antibodies, and developed. Samples were taken 0min (B) and 60min (E) after lysis induction. As a positive 
control, an induced sample of an E. coli C2988J (pBGKB-MOMP) Expression Experiment was used. 
MOMP can also be detected with polyclonal Anti-MOMP-Antibody preparation, even though 
the signal:noise ratio is worse compared to detection via the Myc-tag (see Figure 42). In 
addition to the correct-sized product, two smaller fragments at roughly 16kDa and 35kDa 
are detected. They disappear after lysis induction, suggesting a previous cytoplasmic 
location. 
5.4.5 EXPRESSION/LYSIS OF pBGKB-MOMP IN E. COLI 
NISSLE 
Even though numerous attempts were made, using different midipreps and freshly prepared 
MOPS-competent cells, in my hands it was not possible to co-transform pBGKB-MOMP and 
pGLysivb into E. coli Nissle. 
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5.5 LARGE SCALE EXPRESSION/LYSIS EXPERIMENTS 
For the large scale production of BGs ,fermentation was performed in a volume of 22l LBv pH 
7.2, with antibiotics kanamycin and gentamicin added. In 30min intervals, samples were 
withdrawn to measure OD600nm, check bacterial viability via the microscope, prepare 
Western Blot samples and plate dilutions for cfu determination on count agar plates; flow 
cytometry was performed for live-monitoring of the growth and lysis process. 
Important fermentation parameters such as flow, stirring rate, temperature or pO2 were 
documented using the IRIS software. 
After an initial growth phase at 35°C, protein expression was induced by adding 0.2% L-
arabinose; after 30min of expression for PorB, and after 20min of expression for MOMP, 
lysis was induced by temperature upshift of the culture to 42°C. 
After 120min of lysis, harvesting by Tangential Flow Filtration and killing of viable bacteria 
using β-Propiolactone took place. After washing, the concentrate was aliquoted and 
lyophilized. Plates for cfu determination were incubated at 36°C overnight. 
5.5.1 E. COLI NM522 (pBGKB-PORB, pGLYSIVB) 
FERMENTATION 
After testing several clones of E. coli NM522 (pBGKB-PorB, pGLysivb) for differences in lysis 
efficiency and PorB expression, working stocks of clone A3 of E. coli NM522 (pBGKB-PorB, 
pGLysivb) were prepared. These were used to inoculate an overnight culture for 
fermentation. 
OD600nm values and cfu counts (taken the next day) plotted against time are shown in Figure 
44. 
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Figure 44: OD and cfu values over time during fermentation in 22l of E. coli NM522 (pBGKB-PorB, 
pGLysivb). L-Arabinose was added at time point C (-30min); lysis was induced by increasing the temperature to 
42°C at time point D (0min). 
While both OD600nm and cfu values increase after expression induction, they drop sharply 
after lysis induction (5.45*108cfu/ml at D to 4.09*105cfu/ml at H – a lysis efficiency of 
99.93%). 
No flow cytometry was performed for this fermentation because of malfunctioning 
equipment. Microscopic analysis (see Figure 45) using the membrane potential staining dye 
DiBAC4(3) also showed no killing before lysis induction. The development of BGs is clearly 
seen in Figure 45C after lysis induction by temperature shifting to 42°C. 
A B C 
Figure 45: Light microscopy of samples taken during the fermentation process. Intact cells at time point C after 
45min of growth (A), intact cells at time point D after 30min of protein expression (B) and translucent lysed 
cells at time point F after 60min of lysis (C). 
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Figure 46: IRIS diagram documenting fermentation parameters like pH (regulated at 7.2), temperature 
(35°C during growth and expression, 42°C during lysis), flow rate, stirring rate, oxygen concentration and 
addition of anti-foam. 
In the IRIS diagram of this fermentation (see Figure 46), the oxygen curve is of particular 
interest, which typically registers a sharp drop within minutes of lysis induction, followed by 
a strong increase in oxygen concentration after 30min of lysis. Additionally, anti-foam is 
added after roughly 40min of lysis to counteract the foaming initiated by expulsion of 
cytoplasmic content during lysis. 
Several other specifications as well as follow-up experiments of this particular fermentation 
are detailed in Table 5 below: 
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E. coli NM522 (pBGKB-PorB, pGLysivb) Bacterial Ghosts 
Pre-Culture 
Volume: 4*500ml Additives: Gentamicin + Kanamycin 
Medium type: LBv Other: - 
Date: 2009-10-15 Clone: c. A3 (2009-09-30/ WS 2009-10-15 FHO) 
Starting time: 8:19 Strain: NM522 
End time:  Plasmids: pGLysivb, pBGKB-PorB 
ON culture OD: 5.39 Recombinant Protein Expression: GIII-PorB-Myc-
PolyHis 
Inoculation Volume: 1.6l Expression Induction: L-Arabinose, 0.2% 
Medium: LBv Expression Induction Time Point: C 
Antibiotics: Gentamicin + Kanamycin Lysis Induction: 42°C 
Temperature: 35°C Lysis Induction Time Point: D 
Total Volume: ≈22l Killing: after harvest, 0.075% ß-PL (2*0.0375%) 
Acid: F. A.:       31 units Volume harvested: 20l 
Base: A. W.:     30 units Harvested by: TFF 
Antifoam A:     25 units OD separator flow: - 
Eivb blot: - Yield: 6447mg 
Recombinant blot: OK (by FHO) Particles/mg: 1.69 x 109 
BPL Test: Survivors (by AME) Sterility: OK (by EDZ) 
Microscopy: ok Efficiency: 99.925% 
Table 5:  Data sheet of E. coli NM522 (pBGKB-PorB, pGLysivb) Fermentation 
While some colonies after ß-PL killing could be detected, PCR analysis could not detect 
gentamicin or kanamycin resistance genes in these colonies, suggesting a later 
contamination. Sterility tests of the freeze-dried lyophilisate indicate a sterile product. From 
a total of 20l fermentation volume, harvesting and lyophilisation yielded 6447mg of BGs dry 
weight. Calculating from a cfu count of 5.45*108/ml at the time point of lysis induction, and 
a harvested volume of 20l, the lyophilisate contains 1.69*109particles/mg. 
Western Blot samples taken throughout the fermentation process were separated on a 4-
12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto nitrocellulose, the membrane 
incubated with HRP-coupled-Anti-Myc-Antibodies and developed by chemiluminiscence, as 
seen in Figure 47. Protein GIII-PorB-Myc-PolyHis was expected at a size of 40.8kDa, protein 
PorB-Myc-PolyHis at a size of 38.7kDa. 
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Figure 47: Western Blot of E. coli NM522 (pBGKB-PorB, pGLysivb) Fermentation, using Unstained Protein 
Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES Running 
Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. As a positive control, a sample from a previous small scale 
experiment was used. 
Myc-tagged PorB is detected after induction and reaches its highest concentration after 
60min of expression/30min of lysis. While the concentration slightly decreases afterwards, 
the majority of protein is retained during lysis. 
5.5.2 E. COLI NISSLE (pBGKB-PORB, pGLYSIVB) 
FERMENTATION 
Clone A1 of E. coli Nissle (pBGKB-PorB, pGLysivb) already tested in small scale experiments 
(see 5.4.2 Expression/Lysis of pBGKB-PorB in E. coli Nissle) was used to produce working 
stocks. These were used to inoculate an overnight culture for fermentation. 
OD600nm values and cfu counts plotted against time are shown in Figure 48. 
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Figure 48: OD and cfu values over time during fermentation in 22l of E. coli Nissle (pBGKB-PorB, 
pGLysivb). L-Arabinose was added at time point C (-30min); lysis was induced by increasing the temperature to 
42°C at time point D (0min). 
While both OD600nm and cfu values increase after expression induction, they drop sharply 
after lysis induction (3.36*108cfu/ml at D to 3.45*104cfu/ml at H – a lysis efficiency of 
99.99%). 
A B C 
Figure 49: Light microscopy of samples taken during the fermentation process. Intact cells at time point C after 
45min of growth (A), intact cells at time point D after 30min of protein expression (B) and translucent lysed 
cells at time point F after 60min of lysis (C). 
Microscopic analysis (see Figure 49) using the membrane potential staining dye DiBAC4(3) 
also showed no killing before lysis induction. The development of BGs is clearly seen in 
Figure 49C after lysis induction by temperature shifting to 42°C. Note the typical clustering of 
E. coli Nissle seen for growth in LBv medium before lysis is induced. 
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Flow Cytometry was used to observe the influence of expression of foreign antigen (PorB) 
and induction of lysis on cells. Three exemplary results are given below in Figure 50: 
 
C 
 
1.25µl 
Stain 
 
Speed  
2.8 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 1.83 e 8 0.97 e 6 1.47 e 7 1.99 e 8 
% Gated 70.0% 0.4% 5.6% 76.0% 
 
 
D 
 
1.50µl 
Stain 
 
Speed  
1.6 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 4.85 e 8 0.93 e 6 1.47 e 7 5.01 e 8 
% Gated 81.5% 0.2% 2.5% 84.2% 
 
 
F 
 
1.50µl 
Stain 
 
Speed  
1.2 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 2.32 e 7 1.15 e 7 8.90 e 8 9.25 e 8 
% Gated 2.5% 1.2% 95.1% 98.8% 
 
Figure 50: Flow cytometric analysis of fermentation samples, prior to expression induction (C), after 
30min of expression, prior to lysis induction (D) and after 60min of lysis (F). Samples were stained with the 
indicated volume/ml of DiBAC4(3) and RH414. Gate R1 denotes live, intact cells; R2 dead, intact cells and R3 
dead, lysed cells. 
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While a small amount of particles is gated in the R3 region even before expression or lysis 
induction, no toxic effect of PorB expression during the first 30min can be seen when 
samples C and D are compared. After 60min of lysis (time point F), 95% of particles are gated 
in the R3 (BG) region. 
As seen before in the IRIS diagram, the oxygen concentration drops within minutes of lysis 
induction, only to sharply rise again after roughly 30min of lysis, as seen in Figure 51. 
 
Figure 51: IRIS diagram documenting fermentation parameters like pH (regulated at 7.2), temperature 
(35°C during growth and expression, 42°C during lysis), flow rate, stirring rate, oxygen concentration and 
addition of anti-foam (used to counteract the foaming initiated by expulsion of cytoplasmic content during 
lysis). 
Several other specifications as well as follow-up experiments of this particular fermentation 
are detailed Table 6 below: 
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E. coli Nissle 1917 (pBGKB-PorB, pGLysivb) Bacterial Ghosts 
Pre-Culture 
Volume: 4*500ml Additives: Gentamicin + Kanamycin 
Medium type: LBv Other: pH 7.6 
Date: 2009-11-19 Clone: c.1 (2009-10-22/ WS 2009-11-05 FHO) 
Starting time: 9:18 Strain: E. coli Nissle 1917 
End time: Plasmids: pGLysivb, pBGKB-PorB 
ON culture OD: 6.18 Recombinant Protein Expression: GIII-PorB-Myc-
PolyHis 
Inoc. Volume: 1.4l Expression Induction: Arabinose, 0.2% 
Medium: LBv Expression Induction Time Point: C 
Antibiotics: Gentamicin + Kanamycin Lysis Induction: 42°C 
Temperature: 35°C Lysis Induction Time Point: D 
Total Volume:  ≈22 L Killing: after harvest, 0.075% ß-PL (2*0.0375%) 
Acid: F. A.:       34 units Volume harvested: 20l 
Base: A. W.:     49 units Harvested by: TFF 
Antifoam A:     15 units OD Separator flow: - 
Eivb blot: - Yield: 10376 mg 
Recombinant blot: OK (by FHO) Particles/mg: 7.12 x 108 
BPL Test:  OK (by AME), no survivors Sterility: OK (by EDZ) 
Microscopy: ok, cluster Efficiency: 99.990% 
Table 6:  Datasheet of E. coli Nissle (pBGKB-PorB, pGLysivb) Fermentation 
No survivors after ß-PL killing could be detected, and sterility tests of the freeze-dried 
lyophilisate indicate a sterile product. From a total of 20l fermentation volume, harvesting 
and lyophilisation yielded 10376mg of BGs dry weight. Calculating from a cfu count of 
3.36*108/ml at the time point of lysis induction, and a harvested volume of 20l, the 
lyophilisate contains 7.12*108particles/mg. 
Western Blot samples taken throughout the fermentation process were separated on a 4-
12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto nitrocellulose, the membrane 
incubated with HRP-coupled-Anti-Myc-Antibodies and developed by chemiluminiscence as 
seen in Figure 52. Protein GIII-PorB-Myc-PolyHis was expected at a size of 40.8kDa, and 
protein PorB-Myc-PolyHis at a size of 38.7kDa. 
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Figure 52: Western Blot of E. coli Nissle (pBGKB-PorB, pGLysivb) Fermentation, using Unstained Protein 
Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES Running 
Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-coupled 
Anti-Myc-Antibodies and developed. As a positive control, a sample from a previous small scale experiment 
was used. 
A faint signal of Myc-tagged PorB can first be seen 30min after expression induction (D); 
after 60min of expression/30min of lysis (E), the signal reaches its maximal intensity; in 
contrast to the fermentation in E. coli NM522, where lysis lead to a small but noticeable loss 
of PorB, (almost) no loss of product upon lysis induction is visible in this E. coli Nissle 
fermentation. 
5.5.3 E. COLI NM522 (pBGKB-MOMP, pGLYSIVB) 
FERMENTATION 
Working stocks were prepared from clone A3 of E. coli NM522 (pBGKB-MOMP, pGLysivb). 
These were used to inoculate an overnight culture for fermentation. In contrast to PorB 
fermentations, due to the toxicity of MOMP expression, E-lysis was induced by temperature 
upshift to 42°C already 20min after induction of MOMP expression. 
OD600nm values and cfu counts plotted against time are shown in Figure 53. 
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Figure 53: OD and cfu values over time during fermentation in 22l of E. coli NM522 (pBGKB-MOMP, 
pGLysivb). L-Arabinose was added at time point C (-20min); lysis was induced by increasing the temperature to 
42°C at time point D (0min). 
While OD600nm increases from the time point of induction until lysis induction, the cfu more 
or less stagnates during the whole fermentation, until lysis is induced. After that, both values 
drop sharply (from 6.90*107cfu/ml at time point D to 1.10*104cfu/ml at time point H – a lysis 
efficiency of 99.98%). In contrast to cfu determination, FACS live cell counts do increase by 
50% from the start of the fermentation until lysis is induced (compare Figure 55). 
Microscopic analysis (see Figure 54) using the membrane potential staining dye DiBAC4(3) 
also showed no killing before lysis induction. The development of BGs is clearly seen in 
Figure 54C after lysis induction by temperature shifting to 42°C. 
A B C 
Figure 54: Light microscopy of samples taken during the fermentation process. Intact cells at time point C after 
45min of growth (A), intact cells at time point D after 20min of protein expression (B) and translucent lysed 
cells at time point F after 60min of lysis (C). 
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Flow Cytometry was used to observe the influence of  foreign antigen expression (MOMP) 
and induction of lysis on cells. Three exemplary results are given below in Figure 55: 
C 
 
1.25µl 
Stain 
 
Speed  
3.0 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 3.21 e 8 1.56 e 6 4.71 e 6 3.28 e 8 
% Gated 80.6% 0.4% 1.2% 82.1% 
 
 
D 
 
1.50µl 
Stain 
 
Speed  
1.3 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 3.62 e 8 1.65 e 6 6.53 e 6 3.70 e 8 
% Gated 81.5% 0.4% 1.5% 83.3% 
 
 
F 
 
1.50µl 
Stain 
 
Speed  
1.0 
 
1:1000 
   
 
 R1 - Living R2 - Dead / Intact R3 - Ghost Total Particles 
Count / ml 6.19 e 6 1.50 e 7 4.15 e 8 4.36 e 8 
% Gated 1.4% 3.3% 90.2% 94.8% 
 
Figure 55: Flow cytometric analysis of fermentation samples, prior to expression induction (C), after 
20min of expression, prior to lysis induction (D) and after 60min of lysis (F). Samples were stained with the 
indicated volume/ml of DiBAC4(3) and RH414. Gate R1 denotes live, intact cells; R2 dead, intact cells and R3 
dead, lysed cells. 
 78 Bacterial Ghosts Displaying Chlamydia trachomatis Antigens 
Only a small amount of particles is gated in the R3 region before expression or lysis 
induction, and no toxic effect of MOMP expression during the first 20min can be seen when 
samples C and D are compared. After 60min of lysis (time point F), 90% of particles are gated 
in the R3 (BG) region. 
Important fermentation parameters such as flow, stirring rate, temperature or pO2 are 
documented using the IRIS software and detailed below in Figure 56: 
 
Figure 56: IRIS diagram documenting fermentation parameters like pH (regulated at 7.2), temperature 
(35°C during growth and expression, 42°C during lysis), flow rate, stirring rate, oxygen concentration and 
addition of anti-foam (used to counteract the foaming initiated by expulsion of cytoplasmic content during 
lysis). 
Paralleling previous fermentations, the oxygen concentration drops rapidly upon lysis 
induction, only to sharply rise again after roughly 30min of lysis, as seen in the IRIS diagram. 
Several other specifications as well as follow-up experiments of this particular fermentation 
are detailed in Table 7 below: 
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E. coli NM522 (pBGKB-MOMP, pGLysivb) Bacterial Ghosts 
Pre-Culture 
Volume: 4x500ml Additives: Gentamicin + Kanamycin 
Medium type: LBv Other: pH 7.64 
Date: 2009-12-10 Clone: c. A3 (2009-12-03/ WS 2009-12-07 FHO) 
Starting time: 8:55 Strain: E. coli  NM522 
End time:  Plasmids: pGLysivb, pBGKB-MOMP 
ON culture OD: 5.69 Recombinant Protein Expression: GIII-MOMP-Myc-
PolyHis 
Inoc. Volume: 1.47l Expression Induction: Arabinose, 0.2% 
Medium: LBv Expression Induction Time Point: C 
Antibiotics: Gentamicin + Kanamycin Lysis Induction: 42°C 
Temperature: 35°C Lysis Induction Time Point: D 
Total Volume:  ≈22l Killing: after harvest, 0.075% ß-PL (2*0.0375%) 
Acid: F. A.:   38 units Volume harvested: 20l 
Base: A. W.: 22 units Harvested by: TFF 
Antifoam A: 12 units OD separator flow: - 
Eivb blot: - Yield: 6209mg 
Protein Gel: OK (by FHO) Particles/mg: 2.1 x 108 
BPL Test: OK (by AME), no survivors Sterility: OK (by EDZ) 
Microscopy: ok Efficiency: 99,984% 
Table 7:  Datasheet of E. coli NM522 (pBGKB-MOMP, pGLysivb) Fermentation 
No survivors after ß-PL killing could be detected, and sterility tests of the freeze-dried 
lyophilisate indicate a sterile product. From a total of 20l fermentation volume, harvesting 
and lyophilisation yielded 6209mg of BGs dry weight. Calculating from a cfu count of 
6.90*107/ml at the time point of lysis induction, and a harvested volume of 20l, the 
lyophilisate contains 2.10*108particles/mg. 
Western Blot samples taken throughout the fermentation process were separated on a 4-
12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto nitrocellulose, the membrane 
incubated with HRP-coupled-Anti-Myc-Antibodies and developed by chemiluminiscence, as 
seen in Figure 57. Protein GIII-MOMP-Myc-PolyHis was expected at a size of 46.5kDa, and 
protein MOMP-Myc-PolyHis at 44.4kDa. 
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Figure 57: Western Blot of E. coli NM522 (pBGKB-MOMP, pGLysivb) Fermentation, using Unstained 
Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. As a positive control, a sample from a previous small scale 
experiment was used. 
Myc-tagged MOMP is detected first 50min after induction (not after 20min) and remains at a 
stable level throughout the whole experiment, with no loss occurring during lysis. 
5.6 QUANTIFYING CHLAMYDIAL ANTIGENS IN BGs 
Chlamydial antigens presented in BGs after fermentation were quantified using two different 
techniques: (1) the established protocol of comparing signal strength of a positope of known 
size and concentration and signal strength of known concentrations of lyophilised BGs on a 
Western Blot and (2) the S-Tag system that is based on measuring an enzymatic reaction that 
is proportional to the amount of S-tagged protein in a sample. 
5.6.1 QUANTIFICATION OF PORB IN E. COLI NM522 BGs 
In order to quantify the amount of recombinant PorB per µg E. coli NM522 BGs, the signals 
obtained from a serial dilution of BGs (Techfors Fermentation of E. coli NM522 (pBGKB-PorB, 
pGLysivb), see 5.5.1) with known concentration and a serial dilution of positope (containing 
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the Myc epitope) with known concentration were compared on a Western Blot, as seen in 
Figure 58. 
 
Figure 58: Western Blot of E. coli NM522 (pBGKB-PorB, pGLysivb) BGs and positope, using Unstained 
Protein Molecular Weight Marker (Fermentas). Samples were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. The amount of lyophilized BGs, as well as of positope per lane is 
indicated. 
The chemiluminiscence signals generated by HRP-coupled-Anti-Myc-Antibodies at the site of 
positope and PorB bands were measured using the ChemidocXRS machine; with the 
standard curve provided by the positope, the amount of PorB per µg BG could be calculated, 
as outlined in Figure 59: 
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Figure 59: Quantification curve for E. coli NM522 (pBGKB-PorB, pGLysivb) BGs. Signals generated by 
positope with known concentration are indicated by blue diamonds, the linear regression curve is shown in 
black. Signals generated by BG samples are indicated as detailed in the legend. 
The square of the correlation coefficient is R²=0.902, indicating a good fit of the standard 
curve provided by the positope. Calculated on that basis, Table 8 shows the amounts of PorB 
that are found in E. coli NM522 BGs. 
Lane Amount of BGs Calc. Total Amount of PorB Calc. Amount PorB/µg BG 
U1 1µg 332.72ng 332.72ng 
U2 2µg 475.56ng 237.78ng 
U3 5µg 894.21ng 178.84ng 
U4 10µg 1308.02ng 130.80ng 
U5 20µg 1857.50ng 92.88ng 
Table 8:  Calculating the average amount of PorB per µg of E. coli NM522 BGs 
On average, one microgram of E. coli NM522 BGs contains 194.60 ± 94.35ng PorB. 
Therefore, recombinant PorB constitutes roughly one fifth of the lyophilized BGs. Taking in 
account that only 1µg and 2µg BG samples fall on the standard curve given by the positope, 
a different amount of PorB/µg BG is calculated; if only these two values are included, one 
microgram of E. coli NM522 BGs contains 285.25 ± 67.13ng PorB. 
The molecular weight of PorB of 38.7kDa translates into a mass of 6.42∙10-20g, therefore, one 
microgram of E. coli NM522 BGs contains 4.44∙1012 PorB molecules (using the second 
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calculated value). Assuming a particle count of 1.69∙106 BGs/µg, a single E. coli NM522 BG 
contains 2.63∙106 PorB molecules. 
5.6.2 QUANTIFICATION OF PORB IN E. COLI NISSLE BGS 
For the quantification of recombinant PorB per µg E. coli Nissle BG (Techfors Fermentation of 
E. coli Nissle (pBGKB-PorB, pGLysivb), see 5.5.2), the signals obtained from a serial dilution of 
BGs with known concentration and a serial dilution of positope (containing the Myc epitope) 
with known concentration were compared on a Western Blot, as seen in Figure 60. 
 
Figure 60: Western Blot of E. coli Nissle (pBGKB-PorB, pGLysiv) BGs and positope, using Unstained 
Protein Molecular Weight Marker (Fermentas). Samples were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. The amount of lyophilized BGs, as well as of positope per lane is 
indicated. As a negative control, BGs from an E. coli Nissle (pGLysivb) fermentation were used. 
The chemiluminiscence signals generated by HRP-coupled-Anti-Myc-Antibodies at the site of 
positope and PorB bands were measured using the ChemidocXRS machine; with the 
standard curve provided by the positope, the amount of PorB per µg BG could be calculated, 
as seen in Figure 61: 
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Figure 61: Quantification curve for E. coli Nissle (pBGKB-PorB, pGLysivb) BGs. Signals generated by 
positope with known concentration are indicated by blue diamonds, the linear regression curve is shown in 
black. Signals generated by BG samples are indicated as detailed in the legend. 
The square of the correlation coefficient is R²=0.9695, indicating a very good fit of the 
standard curve provided by the positope. Calculated on that basis, Table 9 details the 
following amounts of PorB are found in BGs. 
Lane Amount of BGs Calc. Total Amount of PorB Calc. Amount PorB/µg BG 
U1 1µg 238.04ng 238.04ng 
U2 2µg 454.18ng 227.09ng 
U3 5µg 807.14ng 161.43ng 
U4 10µg 1582.81ng 158.28ng 
Table 9:  Calculating the average amount of PorB per µg of E. coli Nissle BGs 
On average, one microgram of E. coli Nissle BGs contains 196.21 ± 42.24ng PorB. Therefore, 
recombinant PorB constitutes roughly one fifth of the lyophilized BGs. Taking in account that 
only 1µg and 2µg BG samples fall on the standard curve given by the positope, a different 
amount of PorB/µg BG is calculated; if only these two values are included, one microgram of 
Nissle BGs contains 232.57 ± 7.74ng PorB. 
These values are remarkably similar to the amount of PorB found in E. coli NM522 BGs, 
indicating a good reproducibility using the pBGKB-PorB vector. 
R² = 0.9695 
0 
3000 
6000 
9000 
12000 
15000 
18000 
21000 
0 500 1000 1500 2000 
A
d
j.
 V
o
l.
 [
IN
T
*m
m
²]
 
Concentration [ng/20µl] 
Quantification of PorB in E. coli Nissle Ghosts using Myc-Tag 
Positope 
1µg BG 
2µg BG 
5µg BG 
10µg BG 
Linear 
(Positope) 
 85 Results 
The molecular weight of PorB of 38.7kDa translates into a mass of 6.42∙10-20g, therefore, one 
microgram of E. coli Nissle BGs contains 3.62∙1012 PorB molecules (using the second 
calculated value). Assuming a particle count of 7.12∙105 BGs/µg, a single E. coli Nissle BG 
contains 5.08∙106 PorB molecules. 
5.6.3 QUANTIFICATION OF MOMP IN E. COLI NM522 BGS 
To quantify the amount of recombinant MOMP per µg E. coli NM522 BG (from Techfors 
Fermentation of E. coli NM522 (pBGKB-MOMP, pGLysivb), see 5.5.3), the signals obtained 
from a serial dilution of BGs with known concentration and a serial dilution of positope 
(containing the Myc epitope) with known concentration were compared on a Western Blot, 
as seen in Figure 62. 
 
Figure 62: Western Blot of E. coli NM522 (pBGKB-MOMP, pGLysivb) BGs and positope, using Unstained 
Protein Molecular Weight Marker (Fermentas). Samples were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. The amount of lyophilized BGs, as well as of positope per lane is 
indicated. BGs from a fermentation of E. coli NM522 (pGLysivb) were used as a negative control. 
The chemiluminiscence signals generated by HRP-coupled-Anti-Myc-Antibodies at the site of 
positope and MOMP bands were measured using the ChemidocXRS machine; with the 
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standard curve provided by the positope, the amount of MOMP per µg BG could be 
calculated, as seen in Figure 63: 
 
Figure 63: Quantification curve for E. coli NM522 (pBGKB-MOMP, pGLysivb) BGs. Signals generated by 
positope with known concentration are indicated by blue diamonds, the linear regression curve is shown in 
black. Signals generated by BG samples are indicated as detailed in the legend. 
The square of the correlation coefficient is R²=0.9876, indicating a very good fit of the 
standard curve provided by the positope. Calculated on that basis, Table 10 gives the 
following amounts of MOMP for E. coli NM522 BGs. 
Lane Amount of BGs Calc. Total Amount of MOMP Calc. Amount MOMP/µg BG 
U1 1µg 567.15ng 567.15ng 
U2 2µg 763.64ng 381.82ng 
U3 5µg 1223.16ng 244.63ng 
U4 10µg 1663.95ng 166.40ng 
Table 10:  Calculating the average amount of MOMP per µg of E. coli NM522 BG 
On average, one microgram of NM522 BGs contains 340.00 ± 175.67ng MOMP. Therefore, 
recombinant MOMP constitutes an impressive one third of the lyophilized BGs. 
All samples are out of the range of the standard curve; the sample using 1µg BG comes 
closest to the upper limit of the standard curve, and gives a value of 567.15ng MOMP per 
microgram BG – more than half of the BGs’ dry mass. 
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The molecular weight of MOMP of 44.44kDa translates into a mass of 7.38∙10-20g, therefore, 
one microgram of E. coli NM522 BGs contains 4.61∙1012 MOMP molecules (using the first 
calculated value). Assuming a particle count of 2.10∙105 BGs/µg, a single E. coli NM522 BG 
contains 2.19∙107 MOMP molecules. 
5.6.4 QUANTIFICATION OF RECOMBINANT PROTEINS 
USING THE S-TAG SYSTEM 
Samples were collected during an Expression Experiment of E. coli C2988J (pASK) and an 
Expression/Lysis Experiment of E. coli NM522 (pASK-PorB, pGLysivb) (already described 
above) and treated according to protocol, as detailed in 7.10.3 Quantification Using the S-
Tag System. 
In the case of E. coli C2988J (pASK), the quantification result is shown in Figure 64: 
 
Figure 64: S-Tag Detection Assay, using induced (1) and non-induced (2) samples of E. coli C2988J (pASK). 
Time point 0min is the moment of L-Arabinose addition to (1). 
While the RNAse S activity as measured by A280nm absorption remains at baseline levels in 
non-induced samples (2), and is at baseline levels at the induction point for sample 1 (0min), 
absorption increases rapidly when pASK is induced by addition of 0.2% L-Arabinose. The 
calculated amount of GIII-PolyHis-S-Tag-PolyHis (the gene product of pASK) is 0.002pmol/µl 
at time point 0min, 0.161pmol/µl after 30min and reaches 0.236pmol/µl 60min after 
expression induction, while it stays at 0.004pmol/µl for the non-induced sample. 
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An S-Tag standard sample was used for calculating unknown samples. 
Using samples from a E. coli NM522 (pASK-PorB, pGLysivb) and an E. coli NM522 (pASK, 
pGLysivb) Expression/Lysis Experiment, the following data were collected, as shown in Figure 
65: 
 
Figure 65: S-Tag Detection Assay, using samples of E. coli NM522 (pASK, pGLysivb) (1-2) as well as 
samples of E. coli NM522 (pASK-PorB, pGLysivb) (3-4). Time point 0min is the moment of L-Arabinose addition 
to all samples. Lysis was induced at time point 30min for samples (2) and (4). 
In general, the yield was much lower than in the previous experiment, even after 30min of 
expression, before loss of protein due to lysis might have occurred. In sample 1, where pASK 
expression was induced but no lysis occurred, 0.153pmol/µl are reached after 90min of 
expression, whereas lysis (in sample 2) reduces this number to 0.038pmol/µl. Anyhow, at 
time point 30min (just before lysis induction), no real difference was observed between 
samples 1 and 2. 
Yields for pASK-PorB translation products were even lower, possibly reflecting the larger 
mass of the recombinant protein. After 90min of expression, 0.027pmol/µl PorB are 
detected in samples 3, but when lysis is induced (sample 4) this number is reduced to 
0.015pmol/µl. This is somewhat conflicting with the Western Blot seen in Figure 40, where 
sample E3 does not appear to be twice as intensive as sample E4. 
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6 DISCUSSION 
6.1 TESTING THE S-TAG SYSTEM 
While the S-Tag Assay, as described in the Materials & Methods chapter, is less time 
consuming than a Western Blot (90min compared to roughly 8 hours), it also gives less 
information. While in theory S-tagged proteins can be quantified, the enzymatic reaction 
measured in this assay only gives information about the total S-Tag present in samples. 
Whether the S-Tag is still attached to the recombinant protein, or the protein has undergone 
degradation, is not immediately visible. 
By coupling the signal strength (indicating concentration) with information about protein 
size, Western Blot quantification techniques are intrinsically more informative, and signal 
given by degraded protein can be excluded from the quantification calculation. On the other 
hand, quantification via WB is strongly dependent on the blotting behaviour of the protein 
and needs a standard protein of similar size compared to the protein that has to be 
quantified. The S-Tag system is independent of protein size and a unique standard can be 
used for proteins of any size. Also multiple samples can be analyzed in parallel, making it a 
suitable for tool for the pretesting several clones. To allow quantification using the S-tag for 
BGs, further studies are necessary to implement this technique successfully. 
Given the need of multiple assays for statistically significant data and the necessity of many 
pipetting steps, the established WB quantification system might at the moment be the more 
accurate and more economic mode to quantify recombinant proteins in BGs. For the future, 
a combination of both techniques, using the S-Tag also for detection on WB, is desired. 
6.2 CLONING EXPRESSION VECTORS 
To analyse expression of foreign proteins transported to the periplasm, three different 
vectors were used, differing in the promoter/repressor system, the transport signal to the 
periplasm and the tags used. 
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A new expression system for the export of S-tagged proteins to the periplasm upon L-
arabinose addition was successfully cloned in the form of pASK. Its correct size was proven 
by the correct pattern after restriction digests (see Figure 14). 
The pASK vector was used as an expression backbone vector for PorB, a chlamydial outer 
membrane protein, giving rise to pASK-PorB (see Figure 22). PorB was also successfully 
cloned into an IPTG-inducible, T7 RNA polymerase dependent vector system for the DsbC-
dependent periplasmic export of S-tagged proteins, pET40b. The correct size and restriction 
digest pattern of the resulting plasmid pET40b-PorB was confirmed (see Figure 20). 
Another expression vector used for foreign protein expression and periplasmic export of 
proteins upon L-Arabinose induction is pBGKB. Restriction digests again showed the correct 
size and pattern of pBGKB-PorB (see Figure 17) and pBGKB-MOMP (see Figure 25), the latter 
encoding the chlamydial Major Outer Membrane Protein, MOMP. 
All expression vectors used conferred kanamycin resistance to their host and signalled 
protein transport to the periplasm. No difference in cloning efficiency was observed for the 
different backbone vectors; expected restriction digest patterns were seen after control 
digests, but no sequence analysis was performed. 
6.3 EXPRESSING CHLAMYDIAL ANTIGENS 
After expression vectors were cloned successfully, their function was tested in small scale 
experiments. The effect of recombinant protein expression on viability and on cell shape was 
observed using cfu counting and light microscopy, while protein expression was detected via 
Western Blotting using antibodies against tags fused to the expressed proteins. 
Neither PorB nor MOMP expression and periplasmic transport had notable effect on cell 
shape, but both influenced the viability of bacteria negatively. PorB lead to a decrease in 
growth rate once expression was induced, resulting in cfu stagnation or mild killing (see 
Figure 26 and Figure 31). This effect was even more pronounced for MOMP, where killing 
reached almost 99% after 120min of expression (see Figure 33). For both PorB and MOMP, 
these effects were only seen in the cfu behaviour after more than 30min of protein 
expression. 
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Western Blots were able to detect Myc-tagged PorB (see Figure 27) and MOMP (see Figure 
34) as well as S-tagged PorB from pASK-PorB (see Figure 32), usually faintly after 20min of 
expression, and at saturated levels after 60min. Little or no degradation over time is 
detectable, and no protein is present before the induction of protein expression. 
While the same stagnation/killing effect is seen upon induction of pET40b-PorB (see Figure 
28), no protein could be detected in Western Blots using HRP-coupled-S-Protein, even 
though the gene product of the empty vector pET40b can be detected (see Figure 29), but 
only faintly. No ready explanation can be given for that. From the cfu behaviour it can be 
concluded that PorB is expressed, but to ensure the functionality of the S-Tag, sequencing 
would be necessary. Also changing to another antibody could solve this problem, as low 
efficiency of the HRP-coupled-S-Protein can be seen when trying to detect the gene product 
of pET40b. 
In all cases where a stagnation of killing was observed in the cfu, no such effect was seen in 
OD600nm measurements. Together with the microscopy analysis an increase in cell size can be 
excluded. A possible explanation for this behaviour could be a delayed killing effect by the 
protein, coming into effect only during ON incubation on the plate. This is supported by 
observations via flow cytometry that failed to detect large-scale killing in the first 30min of 
protein expression during fermentations. 
6.4 SMALL SCALE BG PRODUCTION 
Expression plasmids that were shown to be able to express their cloned proteins were co-
transformed with lysis plasmid pGLysivb into E. coli NM522, and if possible, E. coli Nissle to 
perform small-scale Expression/Lysis Experiments in order to test whether foreign antigens 
interfere with lysis and whether they are lost upon lysis induction. 
6.4.1 SMALL-SCALE BG PRODUCTION IN E. COLI NM522 
Plasmids pASK-PorB, pBGKB-PorB and pBGKB-MOMP were used in Expression/Lysis 
experiments in E. coli NM522. In all three cases expression of recombinant proteins under 
the chosen conditions did not negatively influence lysis efficiency, even though in the case of 
 92 Bacterial Ghosts Displaying Chlamydia trachomatis Antigens 
MOMP it is possible that killing contributes to the reduction in cfu used for the calculation of 
lysis efficiency. 
Lysis efficiencies of clones selected for later fermentation were: 
- 99.97% for E. coli NM522 (pASK-PorB, pGLysivb) c. B2 (fermentation not performed) 
- 99.96% for E. coli NM522 (pBGKB-PorB, pGLysivb) c. A3 (used for fermentation) and 
- 99.93% for E. coli NM522 (pBGKB-MOMP, pGLysivb) c. A3 (used for fermentation). 
Western Blot analysis of Expression/Lysis experiments showed similar amounts of expressed 
protein regardless whether lysis was induced or not, implying that little or no loss due to 
lysis occurs. This is especially striking in contrast to other cellular proteins, that are visibly 
lost on lysis induction (see Figure 40). Therefore it can be concluded that the expressed 
proteins are located within the membrane complex. Even though the exact location was not 
determined, the presence of the signal sequence for the periplasm makes a periplasmatic 
localization most likely. 
These findings suggest that neither PorB nor MOMP infer under given conditions with E-
mediated lysis, and E-mediated lysis does not lead to the loss of these antigens in significant 
numbers. 
6.4.2 SMALL-SCALE BG PRODUCTION IN E. COLI NISSLE 
Even though numerous approaches were tried, in my hands it was not possible to transform 
pBGKB-MOMP into E. coli Nissle, neither alone nor in combination with pGLysivb. 
Interestingly, also the precursor plasmid that was used to clone pBGKB-MOMP, pKS-MOMP, 
could not be transformed into E. coli Nissle in my hands. 
In contrast, pBGKB-PorB (as well as its precursor plasmid, pMAL-PorB) was easily (even 
though with reduced efficiencies compared to an E. coli NM522 transformation) transformed 
into E. coli Nissle. 
An Expression/Lysis Experiment of E. coli Nissle (pBGKB-PorB, pGLysivb) showed similar 
results as in E. coli NM522. Lysis was efficient (99.80% for c. A1, that was used for 
fermentation), but nearly one log stage lower than seen in NM522 (pBGKB-Porb, pGLysivb) 
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(99.96% lysis efficiency). Again, lysis did not affect the concentration of PorB in comparison 
with non-lysed samples (see Figure 38). 
6.5 LARGE SCALE BG PRODUCTION 
For the large scale production of BGs carrying chlamydial antigens, E. coli NM522 (pBGKB-
PorB, pGLysivb) c. A3, E. coli NM522 (pBGKB-MOMP, pGLysivb) c. A3, as well as E. coli Nissle 
(pBGKB-PorB, pGLysivb) c. A1 were used for fermentations in 22l volume. Sterility of the final 
product was shown by follow-up experiments. 
Quantification using Western Blots with a known concentration of positope showed that 
PorB constituted 20% of E. coli NM522 (see Table 8) and E. coli Nissle (see Table 9) BGs, and 
that MOMP accounted for one third of the mass of E. coli NM522 BGs (see Table 10). 
In contrast to the pretestings in Expression/Lysis experiments, where lysis efficiency of E. coli 
NM522 (pBGKB-PorB, pGlysivb) was higher than in E. coli Nissle, the opposite was observed 
for fermentations, but a repeated number of fermentations would be necessary for any 
statistically sound conclusions. 
Additionally, in the three fermentations performed, the one using E. coli Nissle had a roughly 
60% higher yield than fermentations using E. coli NM522, but once again, not enough 
fermentations were performed for statistically sound conclusions. 
Furthermore, the calculated particle numbers per microgram of BG dry-weight varies by 
almost a log stage (2.1 x 105 for E. coli NM522 (pBGKB-MOMP, pGLysivb) and 1.69 x 106 for 
E. coli NM522 (pBGKB-PorB, pGLysivb)). In addition to more fermentations, a second, 
independent particle count method would be necessary to test these results. 
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Below in Table 11 is given an overview detailing the large scale BG production: 
 E. coli NM522 
(pBGKB-PorB, 
pGLysivb) 
E. coli Nissle 
(pBGKB-PorB, 
pGLysivb) 
E. coli NM522 
(pBGKB-MOMP, 
pGLysivb) 
Lysis Efficiency: 99.925% 99.990% 99.984% 
Yield: 6447mg 10376mg 6209mg 
Particles/µg: 1.69∙106 7.12∙105 2.1∙105 
ng Antigen/µg BG: 194.60 ± 94.35ng 196.21 ± 42.24ng 340.00 ± 175.67ng 
Proteins/Particle: 2.63∙106 PorB/BG 5.08∙106 PorB/BG 2.19∙107 MOMP/BG 
Table 11: Product details of BGs displaying chlamydial antigens produced during this study. 
Previous studies attempted 
- to display fertility proteins in the periplasm of BGs to induce immunocontraception in 
possums (Schlacher, 2009) 
- to display human choriongonadotropin-ß fused to heat labile enterotoxin B (hCG-ß-
LTB) in the periplasm of BGs for immunocontraception induction (Hodul, 2010) or 
- to display luteinizing hormone releasing hormone (LHRH) in the periplasm of BGs for 
wildlife control by immunocontraception (Champeimont, 2008). 
In these cases, quantified antigen accounted for:  
- 0.35ng/µg BG to 6.35ng/µg BG in the case of LHRH (Champeimont, 2008)  
- 44.51ng/µg BG to 49.75ng/µg BG in the case of hCG-ß-LTB (Hodul, 2010) and  
- 14.6ng/µg BG to 403ng/µg in the case of the possum antigen ZP2C (Schlacher, 2009). 
The quantified yields of roughly 200ng/µg BG for PorB-displaying BGs and 340ng/µg BG for 
MOMP-displaying BGs compare favourably to previous experiments. 
Furthermore, the calculated amounts of proteins per individual BG are found in a range 
between 2.63∙106 PorB/BG for E. coli NM522 (pBGKB-PorB, pGLysivb) and 2.19∙107 
MOMP/BG for E. coli NM522 (pBGKB-MOMP, pGLysivb), and thus are between 30 and 
300times higher than in previous studies where proteins per particle were calculated 
(Champeimont, 2008). 
In previous studies, the particle numbers for fermentations were found to be between 1.65 x 
106/µg and 1.85 x 106/µg (Schlacher, 2009), between 1.89 x 106/µg and 2.85 x 106/µg 
(Champeimont, 2008) and between 1.19 x 105/µg and 1.05 x 106/µg (Hodul, 2010). 
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The calculated particle numbers for fermentations of BGs displaying chlamydial antigens 
were found to be well within these numbers. 
6.6 CHLAMYDIAL ANTIGENS IN BGS 
Regarding the goals stated before this study – to express chlamydial antigens in E. coli, to 
localize them in the periplasm and to retain them there during and after E-lysis, followed by 
their quantification – it can be concluded that they were completed successfully. 
The efficaciousness of BGs as natural adjuvants, displaying chlamydial antigens, to induce 
(protective) immunity has to be addressed in future studies. With BGs derived from E. coli 
NM522 displaying PorB and MOMP, and E. coli Nissle displaying PorB in sufficient, an further 
preclinical studies can be initiated.  
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7 MATERIALS AND METHODS 
7.1 BACTERIAL STRAINS, MEDIA, CULTIVATION 
7.1.1 BACTERIAL STRAINS 
The following strains of Escherichia coli have been used in this work. 
For cloning and plasmid storage, E. coli C2988J is used; E. coli NM522 and E. coli Nissle are 
used for Expression/Lysis experiments, and E. coli C41 is used for experiments with plasmids 
of the pET40b variant, which requires a T7 RNA polymerase (which E. coli C41 carries on its 
chromosome). 
 Escherichia coli K12 NM522: supE thi-1 Δ(Lac-proAB) Δ(mcrB-hsdSM)5 (rK
-mK
+) [F’ 
proAB lacIqZΔM15] – obtained from Stratagene, Heidelberg, Germany (Stratagene, 
2011) 
 Escherichia coli K12 C2988J (NEB 5-alpha competent E. coli): fhuA2 Δ(argF-lacZ)U169 
phoA glnV44 Φ80Δ (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 – obtained 
from New England Biolabs, Ipswich, MA, USA (NEB, 2011) 
 Escherichia coli K12 C41 (OverExpress™ C41(DE3)): F– ompT hsdSB (rB
- mB
-) gal dcm 
(DE3) – obtained from Lucigene, Middleton, WI, USA (Lucigene, 2011) 
 Escherichia coli Nissle 1917: O6:K5:H1 ΔpMut1 ΔpMut2 – obtained from Ardeypharm, 
Herdecke, Germany (Nissle, 1918) 
7.1.2 CULTIVATION MEDIUM 
Bacteria are cultivated in “Lennox Lysogeny Broth” (LBv), 1l of which consists of 10g soy 
peptone, 5g animal product free (vegetable) yeast extract and 5g NaCl, with pH adjusted to 
7.2. 
Plate Count Agar (ROTH) is used for agar plates for cfu counting. 23.5g are dissolved in 1l 
dH2O, autoclaved and poured at ≈45°C using a plate pouring machine. 
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Lennox LB-Agar (ROTH) is used for agar plates supplemented with antibiotics. 35g are 
dissolved in 1l dH2O and autoclaved. Antibiotics are added when agar is hand-warm, and 
plates are poured next to the flame. 
7.1.3 BACTERIAL CULTIVATION 
Bacteria are inoculated from either frozen cryocultures or single colonies on agar plates and 
grown in test tubes in a volume of 5ml LBv plus antibiotic(s) and other additives as needed. 
Samples are incubated at 36°C in an incubating wheel. 
For long time storage, bacterial cultures are kept in 25% v/v glycerol at -70°C (in a total 
volume of 1.8ml). 
7.1.4 ANTIBIOTICS 
Stock solutions are stored at +4°C for immediate use and at -20°C for long time storage. 
From these, necessary dilutions to achieve the final desired concentration in culture media 
are made, as detailed in Table 12. 
Antibiotic [Stock Solution] [Desired Concentration] µl stock solution/5ml 
Ampicillin 50mg/ml 100µg/ml 10 
Gentamicin 25mg/ml 50µg/ml 10 
Kanamycin 10mg/ml 20µg/ml 10 
Table 12:   Antibiotics and their concentration used in this work. 
7.2 CHEMICALS 
Chemicals used for buffers, solutions and media, as well as some ready to use stock solutions 
(e.g. 10x TBS, 20x TAE) are obtained from ROTH (ROTH Carl, Karlsruhe, Germany), except 
noted otherwise. 
For Western Blots, the NuPage System including gels, buffers and chambers is used 
(Invitrogen, Paisley, UK) 
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7.3 USED APPLIANCES 
The following appliances have been used during this work: 
Name Description Manufacturer 
BK7200 Incubator WTB Binder, Tuttlingen, Germany 
Sigma 3K30 Cooling centrifuge Sigma Aldrich, St. Louis, MO, USA 
Biofuge pico Tabletop centrifuge Heraeus, Hanau, Germany 
Minispin Tabletop centrifuge Eppendorf, Hamburg, Germany 
Uniflow UVUB 1200 
Biohazard 
Laminar Flow Kojair, Vilppula, Finland 
Spectronic 20+ Nose flask photometer Milton Roy, Ivyland, PA, USA 
UV-160 Spectrophotometer Shimadzu, Kyoto, Japan 
DW spiral plater Spiral plater Don Whitley Scientific, Shipley, UK 
ProtoCOL 92000 Colony counter Bartelt Labor- und Datentechnik, Graz, 
Austria 
ChemidocXRS Gel detection system Bio-Rad, Hercules, CA, USA 
Lyolab B Secfroid Lyophilisator Inula, Vienna, Austria 
iCycler IQ PCR machine Bio-Rad, Hercules, CA, USA 
Leica DMRB Microscope Microscope Leica Microsystems, Wetzlar, Germany 
CyFlow Flow Cytometry Analyzer Partec, Görlitz, Germany 
Techfors 30l Fermenter Infors HT, Bottmingen, Switzerland 
Table 13:  List of appliances and machines and their manufacturers used in this work. 
7.4 BUFFERS AND SOLUTIONS 
7.4.1 50% GLYCEROL 
- 25ml dH2O 
- 25ml 100% Glycerol 
- Mix well and autoclave before using 
7.4.2 0.85% SALINE 
- 8.5g NaCl 
- Fill up to 1l with dH2O 
- Distribute to test tubes using a dispenser for 9.0ml and 9.9ml, autoclave before using 
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7.4.3 MOPS I SOLUTION 
- 10.47g MOPS (100mM) 
- 0.74g CaCl2 x 2H2O (10mM) 
- 0.6g RbCl2 (10mM) 
- Dissolve in 400ml dH2O 
- Adjust pH to 7.0 with KOH 
- Fill up to 500ml and autoclave before using 
7.4.4 MOPS II SOLUTION 
- 10.47g MOPS (100mM) 
- 5.15g CaCl2 x 2H2O (70mM) 
- 0.6g RbCl2 (10mM) 
- Dissolve in 400ml dH²O 
- Adjust pH to 6.5 with KOH 
- Fill up to 500ml and autoclave before using 
7.4.5 20% L-ARABINOSE STOCK SOLUTION 
- 20g L-Arabinose 
- Fill up to 100ml with dH2O 
- Sterilize by filtration (Steritop 0.22µm pore size, obtained from Millipore, Billerica, 
MA, USA) 
7.4.6 ANTIBIOTIC STOCKS 
- Weigh in antibiotics: 
o 2g D(-)-α-aminobenzylpenicillin sodium salt (Ampicillin) for a stock 
concentration of 50mg/ml 
o 0.4g Gentamicin sulfate for a stock concentration of 10mg/ml 
o 1g Kanamycin monosulfate for a stock concentration of 25mg/ml 
- Dissolve and fill up to 40mg with dH2O 
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- Sterilize via filtration using syringes (Millex filters, obtained from Millipore, Billerica, 
MA, USA) 
- Stocks are aliquoted into 1ml aliquots (ampicillin) or 8ml aliquots (gentamicin, 
kanamycin) and stored at 4°C during use or at -20°C for long-time storage. 
7.4.7 1x TRIS-ACETATE-EDTA (TAE) BUFFER 
- 50ml 20x TAE stock solution 
- 950ml dH2O 
7.4.8 AGAROSE GEL 
- Weigh in appropriate amount of agarose (e.g. 3g for 1% gel) 
- Dissolve in 300ml 1x TAE buffer 
- Melt in the microwave until a clear solution is reached 
- Cool down on magnetic stirrer to ≈40°C 
- Pour into gel electrophoresis tray with appropriate combs 
7.4.9 1x GEL RED NUCLEIC ACID GEL STAIN SOLUTION 
- 15µl GelRed (obtained from Biotium, Hayward, CA, USA) 
- 5ml 1M NaCl 
- 45ml dH2O 
- Replace after 3-4 days of using 
7.4.10 1x TRIS-BUFFERED SALINE (TBS) 
- 100ml 10x TBS stock solution 
- 900ml dH2O 
7.4.11 1x TRIS-BUFFERED SALINE TWEEN-20 (TBST) 
- 100ml 10x TBST stock solution 
- 900ml dH2O 
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7.4.12 1x NUPAGE SAMPLE BUFFER 
- 6.5ml 1x TBS 
- 2.5ml NuPAGE® LDS Sample Buffer (4x) 
- 1ml NuPAGE® Reducing Agent (10x) 
7.4.13 1x NUPAGE MES RUNNING BUFFER 
- 50ml 20x NuPAGE® MES Running Buffer 
- 950ml dH2O 
7.4.14 1x TRANSFER BUFFER 
- 50ml 20x NuPAGE® Transfer buffer 
- 100ml Methanol 
- 850ml dH2O 
7.4.15 1x BLOCKING SOLUTION 
- 3ml 10x Blocking Solution 
- 27ml dH2O 
7.4.16 PONCEAU-S MEMBRANE STAIN SOLUTION 
- 0.2g Ponceau-S 
- 3.0g Trichloric Acetic Acid 
- Dissolve in and fill up 100ml with dH2O 
- Can be reused multiple times 
7.4.17 LUMINOL CHEMILUMINISCENCE DEVELOPING AGENT 
- Mix 2ml of solution A with 2ml of Solution B (Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA, USA) directly before use 
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7.5 ENZYMES 
Enzymes are purchased either from Fermentas (Thermo Fischer Scientific, Waltham, MA, 
USA) or New England Biolabs. 
Manufacturer’s instructions are followed and buffers supplied with enzymes are used when 
performing restriction digests, ligations, PCR, and other enzymatic reactions. 
7.6 MICROBIOLOGICAL TECHNIQUES 
7.6.1 MOPS-COMPETENT CELLS 
- Inoculate 500ml LBv medium with an overnight culture and grow in a shaking water 
bath at +36°C until OD600 of ≈0.5 
- Centrifuge 10min at +4°C at 1660g 
- Decant supernatant 
- Resuspend pellet in 100ml MOPS I and keep on ice for 10min 
- Centrifuge again for 10min at +4°C at 1660g 
- Decant supernatant 
- Resuspend pellet in 100ml MOPS II and keep on ice for 30min 
- Centrifuge for 10min at +4°C at 1660g 
- Decant supernatant 
- Resuspend pellet in 8ml MOPS II and 3ml 50% glycerol  
- Keep 10min on ice 
- Aliquot in 100µl portions and freeze at -70°C 
- Check competent cells by microscopy and single cell strike on LB agar plates. 
7.6.2 TRANSFORMATION OF MOPS-COMPETENT CELLS 
- Add DNA (e.g. 2µl of miniprep DNA or up to 10µl of ligation) to a 100µl aliquot of 
competent cells 
- Keep 30min on ice 
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- Heat shock at +36°C or +42°C for 2min (depending whether a thermosensitive 
plasmid is used) 
- Keep 5min on ice 
- Add 700µl of medium and regenerate for 1h at proper temperature 
- Strike cells on LB agar plates with the corresponding antibiotics (100µl and the 
remaining rest) 
- Incubate agar plates overnight at +36°C 
7.6.3 ISOLATION OF PLASMID DNA (MINIPREP) 
Between 1.5ml and 3ml of an overnight culture are harvested via centrifugation and the 
plasmid DNA is isolated from the pellet using the small volume PeqGOLD Miniprep Kit I 
(PeqLab, Erlangen, Germany), following the manufacturer’s instructions. (PeqLab, 2011) 
Up to 60µl of plasmid DNA solution are isolated and used directly or stored at -20°C. 
7.6.4 ISOLATION OF PLASMID DNA (MIDIPREP) 
100ml LBv (with selective antibiotic(s) added) are inoculated in the evening and grown 
overnight in a shaking water bath at +35°C. Cells are harvested via centrifugation and 
plasmid DNA is isolated from the pellet using Promega’s PureYield™ Plasmid Midiprep 
System (Promega, Madison, WI, USA), following the manufacturer’s instructions. (Promega, 
2011) 
DNA is eluted twice, first in 1000µl (Elution 1 – E1) and secondly in 300µl (E2); DNA 
concentration and purity is determined by absorption measurements at A260nm and A280nm, 
using the empirical equation: 
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7.7 ENZYMATIC REACTIONS 
7.7.1 RESTRICTION DIGESTS 
For site-specific restriction digests, FastDigest enzymes by Fermentas are used. Digests are 
carried out at +37°C for at least 15min. After digestion is complete, fragment lengths are 
routinely checked on agarose gels. Preparative digests are either excised and eluted from 
the agarose gel, or directly purified using columns (see below). 
7.7.1.1 SMALL SCALE (CONTROL) DIGEST 
- 8µl of miniprep plasmid DNA or 3µl of midiprep plasmid DNA 
- 9µl (miniprep) or 14µl (midiprep) dH2O 
- 2µl 10x FastDigest buffer 
- 1µl FastDigest enzyme 
7.7.1.2 LARGE SCALE (PREPARATIVE) DOUBLE DIGEST 
- 34µl midiprep DNA 
- 4µl 10x FastDigest buffer 
- 1µl FastDigest enzyme 1 
- 1µl FastDigest enzyme 2 
Note: incubate at least 60min to account for higher amount of DNA 
7.7.2 ISOLATION OF DNA FRAGMENTS 
Doubly-digested DNA is run on agarose gels to check the quality of the digest and to purify 
correct-sized fragments. Bands corresponding to the desired DNA fragments are excised 
from the gel under low intensity UV light. The gel is then liquefied and the DNA eluted using 
the PureLink™ Quick Gel Extraction Kit from Invitrogen (Invitrogen, Paisley, UK), following 
the manufacturer’s instructions. (Invitrogen, 2011) 
PCR product is cleaned up using the PureLink™ PCR Purification Kit (Invitrogen, Paisley, UK), 
following the manual. (Invitrogen, 2011) 
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7.7.3 LIGATION 
- For standard ligation, prepare the following mix: 
o 3µl plasmid DNA 
o 5µl insert DNA 
o 2µl 10mM ATP 
o 2µl 10x T4 DNA Ligase Buffer 
o 7µl dH2O 
o 1µl T4 DNA ligase (NEB) 
- Incubate at +4°C overnight or at room temperature for 180min 
Note: Different vector:insert ratios may be necessary; a control ligation including only the 
insert (or the vector) may be included to check ligation ability of the insert (or the vector) 
itself. 
7.8 PCR AMPLIFICATION 
Target DNA sequences are amplified using PCR with sequence specific binding primers that 
have incorporated restriction sites used for cloning in their non-binding sites. 
Generally, a small scale Taq test PCR is performed first to assess whether a correct-sized 
product is synthesized. This is followed by a small scale Pfu test PCR, which in turn (if 
correctly performed) is followed by a large scale Pfu production PCR. 
7.8.1 TAQ TEST PCR 
Materials are thawed on ice. The 2x PCR Master Mix (Fermentas) contains dNTPs, 
polymerase and the needed buffer. To ensure minimum contamination, pipetting is done 
under the laminar flow hood. 
- Prepare master mix on ice: 
o 50µl  2x PCR Master Mix 
o 1µl Primer 1 (50pmol/µl) 
o 1µl Primer 2 (50pmol/µl) 
o 40µl dH2O 
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- Pipette into three labelled PCR tubes: 
o 23µl master mix + 2µl template DNA   – tube 1 
o 23µl master mix + 1µl template DNA + 1µl dH2O  – tube 2 
o 23µl master mix + 2µl dH2O (negative control)  – tube 3 
- Run the following PCR program: 
o Step 1:  Denaturation  95°C 3min 
o Step 2 (30x): 
 Denaturation  95°C 30sec 
 Annealing  Tm°C 30sec 
 Elongation  72°C 1min/1000bp 
o Step 3: Final Elongation: 72°C 10min 
- Check quality of PCR product on agarose gel. 
7.8.2 SMALL SCALE PFU TEST PCR 
Materials are thawed on ice. To ensure minimum contamination, pipetting is done under the 
laminar flow hood. 
- Prepare master mix on ice: 
o 10µl 10X Pfu Buffer 
o 10µl dNTPs (2mM) 
o 1µl Primer 1 (50pmol/µl) 
o 1µl Primer 2 (50pmol/µl) 
o 1µl Pfu Polymerase (Fermentas) 
o 69µl dH2O 
- Pipette into three labelled PCR tubes: 
o 23µl master mix + 2µl template DNA   – tube 1 
o 23µl master mix + 1µl template DNA + 1µl dH2O  – tube 2 
o 23µl master mix + 2µl dH2O (negative control)  – tube 3 
- Run the following PCR program: 
o Step 1:  Denaturation  95°C 3min 
o Step 2 (30x): 
 Denaturation  95°C 30sec 
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 Annealing  Tm°C 30sec 
 Elongation  72°C 1min/1000bp 
o Step 3: Final Elongation: 72°C 10min 
Check quality of PCR product on agarose gel. 
7.8.3 LARGE SCALE PFU PRODUCTION PCR 
Materials are thawed on ice. To ensure minimum contamination, pipetting is done under the 
laminar flow hood. 
- Prepare master mix on ice: 
o 30µl 10X Pfu Buffer 
o 30µl dNTPs (2mM) 
o 3µl Primer 1 (50pmol/µl) 
o 3µl Primer 2 (50pmol/µl) 
o 3µl Pfu Polymerase (Fermentas) 
o 207µl dH2O 
- Pipette into three labelled PCR tubes (as control): 
o 23µl master mix + 2µl template DNA   – tube 1 
o 23µl master mix + 1µl template DNA + 1µl dH2O  – tube 2 
o 23µl master mix + 2µl dH2O (negative control)  – tube 3 
- Pipette into four labelled PCR tubes (for production) 
o 46µl master mix + 4µl template DNA   – tube 4 
o 46µl master mix + 2µl template DNA + 2µl dH2O (3x) – tubes 5 - 7 
- Run the following PCR program: 
o Step 1:  Denaturation  95°C 3min 
o Step 2 (30x): 
 Denaturation  95°C 30sec 
 Annealing  Tm°C 30sec 
 Elongation  72°C 1min/1000bp 
o Step 3: Final Elongation: 72°C 10min 
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Check quality of PCR product on agarose gel. Purify PCR product of tubes 5 – 7 and use for 
downstream applications. 
7.9 USED PRIMERS 
All primers are ordered from and synthesized by Microsynth (Microsynth, Balgach, 
Switzerland). Sequence specific binding regions are coloured green, introduced restriction 
sites are coloured red. An apostrophe (‘) denotes the position where the restriction enzyme 
cleaves. 
Note: In the case of the pASK reverse primer, the restriction site is also a binding site. 
The melting temperature Tm has been calculated using the (crude) empiric equation: 
                                 
Name Enzyme Direction Sequence (5’ – 3’) Tm 
pBGKB-PorB KpnI Fwd ATATAGGTAC’CATGCCTGCGGGGAATCCG 60°C 
pBGKB-PorB EcoRI Rev ATATAG’AATTCCGAATTGGAATCCTCCGGAGA 60°C 
pASK BspHI Fwd TATATT’CATGAGTCATCACCATCACCATCACTC 60°C 
pASK SalI Rev TATATG’TCGACGGAGCTCGAATTC 60°C 
pET40b-PorB HindIII Fwd TATATA’AGCTTATGCCTGCGGGGAATCCG 60°C 
pET40b-PorB XhoI Rev TATATC’TCGAGGAATTGGAATCCTCCGGAGA 60°C 
pBGKB-MOMP KpnI Fwd TATATGGTAC’CCGAAGCGGAATTGTGCATTTAC 58°C 
pBGKB-MOMP BglII Rev TATATA’GATCTCCTGTGGGGAATCCTGCT 60°C 
Table 14:  Primers, their sequences, Tm and the restriction sites introduced by them. 
7.10 ANALYTICAL TECHNIQUES 
7.10.1 AGAROSE GEL ELECTROPHORESIS 
Agarose gels are poured with concentrations of 1% for fragments ranging from 103 – 104bp 
or 2% for fragments smaller than 103bp. For control digests, small-welled gels that can 
accommodate 10µl samples are used. For preparative gels, large wells that hold up to 20µl 
samples are used. 
For fragments ranging from 103 – 104bp, 5µl of GeneRuler™ 1kb DNA Ladder (Fermentas) are 
used as a size marker. For smaller fragments, 5µl of O'GeneRuler™ 50bp DNA Ladder 
(Fermentas) are used. 
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10µl samples are mixed with 2µl of 6x Loading Dye (Fermentas) and loaded onto the gel. 
Gels are run at 160V until the loading dye’s lower front reaches the gel’s end, incubated on a 
shaker in 1x GelRed solution for 15min, exposed to UV radiation and photographed using the 
ChemiDoc. 
7.10.2 WESTERN BLOT ANALYSIS 
For separation of proteins according to their electrophoretic mobility followed by blotting 
and antibody detection, the Novex NuPAGE® Bis-Tris Electrophoresis System using the XCell 
SureLock mini-cells (Invitrogen) has been used according to the manufacturer’s instructions. 
(Invitrogen, 2011) 
As a size marker, the Unstained Protein Molecular Weight Marker, ranging in size from 14.4 
to 116kDa has been used (Fermentas). 
7.10.2.1 SCALING THE SAMPLE AMOUNT 
For Western Blot analysis, samples can be gathered from expression experiments (live cells), 
expression and/or lysis experiments (lysed bacteria) or samples can be lyophilized BGs. 
Additionally, for quantification purposes it is necessary to establish a standard curve using a 
dilution series. Sample preparation protocols are explained in the following sections. 
7.10.2.1.1 USING A BACTERIAL CULTURE 
From an ongoing experiment, 1ml of culture are withdrawn under sterile conditions and 
centrifuged for 3min at 17,000g. Supernatant is removed and the ensuing pellet can either 
be stored at -20°C or prepared for Western Blots directly (see below) according to OD600nm 
values: 
Before lysis induction : OD600nm x 250 = volume in µl of 1x NuPAGE sample buffer 
After lysis induction : highest OD600nm x 250 = volume in µl of 1x NuPAGE sample buffer 
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7.10.2.1.2 USING LYOPHILIZED BGS 
10mg of BGs are weighed in using an analytical balance and dissolved in 1000µl dH2O using 
vigorous vortexing. 200µl of the BG suspension are mixed with 200µl of 2x NuPAGE sample 
buffer and incubated for 10’ at +99°C (1:2 dilution). 
After centrifugation at 17,000g for 3min, 100µl are mixed with 400µl 1x NuPage sample 
buffer (1:5 dilution) to give a concentration of 1µg/µl. 
To establish standard dilutions, 2µl, 5µl, 10µl and 20µl of the 1µg/µl sample of the BGs are 
filled up with 1x NuPAGE sample buffer to 20µl and loaded onto a gel. 
7.10.2.1.3 QUANTIFICATION USING A POSITOPE 
In order to quantify proteins, a detectable standard with a known concentration of 25ng/µl, 
called Positope (Invitrogen) is used for a serial dilution. 
60µl of the positope (already delivered in sample buffer) are incubated at +99°C for 5min. 
20µl of the positope are directly applied to the gel, the remainder is diluted with 40µl 1x 
NuPAGE sample buffer (1:2 dilution). These serial dilutions are repeated twice, and 20µl of 
each are loaded onto the gel, giving the following standards: 
- Std1: 20µl positope are directly applied to the gel 500ng / 20µl 
- Std2:  40µl positope + 40µl NuPAGE sample buffer 250ng / 20µl 
- Std3:  40µl Std2 + 40µl NuPAGE sample buffer  125ng / 20µl 
- Std4:  40µl Std3 + 40µl NuPAGE sample buffer  62.5ng / 20µl 
7.10.2.2 SAMPLE PREPARATIONS 
- Dissolve pellet in the appropriate volume 1x NuPAGE sample buffer 
- Vortex vigorously 
- Incubate at +99°C for 10min 
- Spin down at 17,000g for 3min 
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7.10.2.3 SDS-PAGE 
- For SDS-PAGE, pre-cast 10 well NuPAGE® Novex 4-12% Bis-Tris Gels (Invitrogen) are 
used with 1x MES running buffer 
- Load 20µl of prepared samples and 5µl of protein marker into the pre-cast wells 
- Run SDS-PAGE at 180V according to the protocol (see above) 
7.10.2.4 TRANSFER 
- A semi-dry blotting sandwich with Whatman paper soaked in 1x transfer buffer is 
assembled in an XCell II Blot module according to the manufacturer’s instructions 
(see above) 
- Proteins separated through electrophoresis are transferred onto 0.2µm nitrocellulose 
for 60min at 30V (one gel per apparatus) or at 60V (two gels per apparatus) 
- Successful transfer of proteins onto the nitrocellulose membrane is controlled via 
Ponceau-S staining, allowing the labelling of marker bands. Ponceau-S is afterwards 
rinsed off with dH2O. 
7.10.2.5 BLOCKING 
- The membrane is incubated in 30ml 1x RotiBlock solution 
- Incubation is at least 90min on the shaker at room temperature or over night at +4°C 
7.10.2.6 ANTIBODY INCUBATION 
- The membrane is washed with 1x TBST for 3x 5min, 1x 10min 
- The membrane is incubated with the primary antibody diluted in 10ml 1x TBS 
- The membrane is washed again with 1x TBST (1x TBS if Streptavidin-HRP is used) for 
3x 5min, 1x 10min 
- If necessary, the membrane is incubated with a secondary antibody diluted in 10ml 
1x TBS, 0.3% BSA, 0.05% NaN3 
- Afterwards, the membrane is washed again with 1x TBST for 3x 5min, 1x 10min 
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7.10.2.7 WESTERN BLOT DEVELOPMENT 
- Incubate membrane in 4ml Luminol Developing Agent for 3min at the shaker 
- Photograph the membrane in white light using the Chemidoc XRS 
- Shut off the Chemidoc’s lamps, expose the membrane for a total of 200sec to the 
camera 
- Combine the white-light photograph and the chemiluminiscence photograph using 
Quanitity One software, and quantify signal strength if applicable. 
7.10.3 QUANTIFICATION USING THE S-TAG SYSTEM 
- Harvest 1ml of bacterial culture by centrifugation; use samples from cultures not 
carrying an S-Tag encoding plasmid as blank 
- Remove supernatant, resuspend pellet in 100µl of 1% SDS. Vortex thoroughly and 
heat at +70°C for 10min 
- Centrifuge for 1min at max speed and transfer supernatant to a new tube. Dilute 10-
100fold in dH2O 
- Assemble the following components in a set of sterile 1.5ml microcentrifuges: 
 Tube 1 Tube 2 Tube 3 
dH2O 348µl 346µl 346µl 
S-Tag Standard - 2µl 2µl 
Sample Lysate - - 2µl 
Blank Lysate 2µl 2µl - 
10x S-Tag Assay Buffer 40µl 40µl 40µl 
S-Tag Grade S-Protein 10µl 10µl 10µl 
- Incubate the tubes at +37°C for exactly 5min 
- Stop the reaction by adding 100μl ice-cold 25% TCA, vortex and place on ice for 5min 
- Centrifuge the tubes at max speed for 10min 
- Read the absorbance of the supernatants at A280nm. Zero the spectrophotometer with 
sample #1 
- To calculate the amount of S-tagged protein in the sample, use the following 
equation: 
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7.11 USED ANTIBODIES 
Antibodies were used to detect antigens on Western Blots. The biotinylated E-Protein used 
for lysis could be detected via HRP-conjugated streptavidin; for detection of MOMP, a 
polyclonal antibody was used. Genes cloned into expression vectors were fused either to a 
PolyHis-Tag, a Myc-Tag or both, and could be detected via the corresponding antibodies, of 
which an overview is given below. 
7.11.1 PRIMARY ANTIBODIES 
 
Name Isolated from Specificity Dilution Source 
Anti-MOMP-AB Goat C. trachomatis MOMP 1:500 in TBS Santa Cruz 
Biotechnology 
Table 15:  Primary, non-HRP-coupled antibodies used during this work 
7.11.2 HRP-COUPLED ANTIBODIES 
 
Name Isolated from Specificity Dilution Source 
Anti-Goat-HRP Rabbit Goat-IgG 1:5000 in TBS Sigma-Aldrich 
Streptavidin-HRP n/a Biotin 1:5000 in TBS Invitrogen 
S-Protein-HRP n/a S-Tag 1:5000 in TBS Novagen 
Anti-His-HRP Mouse C-terminal (His)6 1:5000 in TBS Invitrogen 
Anti-Myc-HRP Mouse EQKLISEEDL 1:5000 in TBS Invitrogen 
Table 16:  HRP-coupled primary and secondary antibodies used during this work 
7.12 GROWTH, EXPRESSION AND LYSIS STUDIES 
(NOSEFLASKS) 
7.12.1 GROWTH AND LYSIS (SMALL SCALE) 
E. coli NM522 carrying a lysis plasmid is inoculated in 5ml LBv plus antibiotic and grown 
overnight at +36°C. 
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100ml nose flasks with 25ml LBv plus antibiotic and a magnetic stirrer are inoculated with 
≈1ml over night culture (starting OD600nm should be at 0.1) and grown in a water bath at 
+36°C at a stirring rate of 300rpm. OD600nm measurements are taken using a noseflask 
spectrophotometer until an OD600nm of 0.5 is reached. Lysis is then induced, for 
thermosensitive lysis plasmids by transferring nose flasks into a second water bath at +42°C. 
Lysis is observed for 120min. 
7.12.1.1 MICROSCOPIC OBSERVATION 
10µl of culture are withdrawn at regular intervals and observed using a microscope, first to 
assess viability and growth, and later to look for BGs. These appear translucent in the 
microscope (as opposed to live or dead cells), with darker spots accounting for membrane 
engulfments due to E-lysis. 
7.12.1.2 DETERMINATION OF LYSIS EFFICIENCY VIA CFU 
In order to assess the efficiency of the lysis process, colony forming unit (cfu) counts are 
performed at regular intervals. 
100µl of culture are withdrawn at regular intervals (at least twice before lysis induction, to 
assess the growth rate of the bacterial culture before lysis takes place) and diluted in 9.9ml 
0.85% saline (102 dilution). Samples are further diluted to 103 – 106 in respect to the OD600nm 
and the status of the culture (see Table 17). 
Before Lysis Induction After Lysis Induction 
OD600 Dilution OD600 Dilution 
<0.20 102 1.00 – 2.00 105 
0.20 – 0.50 104 0.50 – 1.00 104 
0.50 – 1.00 105 0.20 – 0.50 103 
1.00 – 2.00 106 <0.20 102 
Table 17:  Dilutions used for plating of cultures before and after lysis induction 
From the respective dilutions, 50µl are plated in duplicates in logarithmic manner on count 
agar plates using a spiral plater. After overnight incubation at +36°C, plates are counted 
using the Colony Counter machine and cfu counts per ml calculated. 
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7.12.2 GROWTH AND EXPRESSION (SMALL SCALE) 
E. coli NM522 carrying an expression plasmid is inoculated in 5ml LBv plus antibiotic and 
grown over night at +36°C. 
100ml nose flasks with 25ml LBv plus antibiotic and a magnetic stirrer are inoculated with 
≈1ml over night culture (starting OD600nm should be at 0.1) and grown in a water bath at 
+36°C at a stirring rate of 300rpm. OD600nm measurements are taken using a noseflask 
spectrophotometer until an OD600nm of ≈0.35 is reached, when expression is induced by 
adding a chemical inducer at an appropriate concentration (e.g. L-arabinose with a final 
concentration of 0.2% for plasmids using the pBAD promoter system). 
Like in a lysis experiment, cfu counts and microscopy analyses are performed to assess the 
influence of foreign protein expression on the viability, shape and size of bacteria. 
Additionally, aliquots of 1ml are withdrawn for later Western Blot analysis. These samples 
are also taken at least once before expression induction to distinguish between non-induced 
baseline expression and induced expression. 
Samples are centrifuged for 3min at 17,000g; after the withdrawal of supernatant, pellets 
can be stored at -20°C. 
7.12.3 GROWTH, EXPRESSION AND LYSIS (SMALL SCALE) 
E. coli NM522 carrying expression and lysis plasmids is inoculated in 5ml LBv plus antibiotics 
and grown over night at +36°C. 
100ml nose flasks with 25ml LBv plus antibiotics and a magnetic stirrer are inoculated with 
≈1ml overnight culture (starting OD600nm should be at 0.1) and grown in a water bath at 
+36°C at a stirring rate of 300rpm. OD600nm measurements are taken using a noseflask 
spectrophotometer until an OD600nm of ≈0.35 is reached, when expression is induced by 
adding a chemical inducer at an appropriate concentration (e.g. L-arabinose with a final 
concentration of 0.2% for plasmids using the pBAD promoter system). 
Depending on the  toxicity of the expressed gene, interference of the expressed gene with 
lysis and the desired accumulation of the expressed gene, lysis can be co-induced with 
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expression induction, or induced at a later time point, by shifting to +42°C (for a 
thermosensitive lysis plasmid). 
Cfu counts and microscopy analysis are performed to assess the influence of foreign protein 
expression on the viability, shape and size of bacteria and later, E-lysis. Additionally, aliquots 
of 1ml are withdrawn for later Western Blot analysis. These samples are also taken at least 
once before expression induction to distinguish between non-induced baseline expression 
and induced expression. 
Samples are centrifuged for 3min at 17,000g. After the withdrawal of supernatant, pellets 
can be stored at -20°C. 
The typical setup of an Expression/Lysis experiment can be seen in Table 18 below. The 
intervals between inoculation, expression induction and lysis induction at time point 0min 
are subject to variations and dependent on bacterial growth rate; typical approximate values 
are given for illustration only. Expression is induced at time point “B”, lysis at time point “C”. 
Time App. OD600nm Sample OD600 Microscopy CFU Western Blot 
≈ -120min 0.10  √    
≈ -60min   √    
≈ -40min 0.25 A √  √  
≈ -20min 0.35 B √ √ √ √ 
0min 0.50 C √ √ √ √ 
20min  D √  √ √ 
40min  E √  √ √ 
60min  F √ √ √ √ 
90min  G √  √ √ 
120min  H √ √ √ √ 
Table 18:  Typical setup of an Expression/Lysis experiment; expression time (time difference 
between points B and C) is subject to deliberations considering toxicity of the expressed protein and expected 
yield 
7.13 GROWTH, EXPRESSION AND LYSIS (FERMENTATION) 
For the large scale production of BGs, fermentation is performed in a 30l fermenter, using 
22l LBv as a medium. 
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7.13.1 PREPARATIONS, STERILITY AND MONITORING 
LBv medium is autoclaved (30min at +121°C) at least 18h prior to use, from which time on 
the conditions inside the fermenter are monitored using the IRIS software, which gives 
online information about pH, temperature, oxygen saturation and flow. 
Blank samples of medium taken from the fermenter prior to inoculation are plated on plate 
count agar to verify sterility. A second blank sample is taken after addition of antibiotics. 
After setting the pO2 value to 100% of the fully saturated medium, standard conditions are 
set and regulated by the IRIS software and documented in the fermentation report. 
7.13.2 OVERNIGHT CULTURE 
For the overnight culture, four 2l flasks containing 500ml medium plus antibiotics are 
inoculated from glycerol stocks, with 800µl stock per flask (necessitating two glycerol stocks 
with 1.8ml of cryoculture each for one fermentation). 
The flasks are incubated overnight at +34°C in a shaking water bath. 
7.13.3 FERMENTATION PROCESS 
After inoculating the fermenter with overnight culture to an OD600nm ≈0.4, growth is 
monitored and 50ml samples are taken every 30min via the sterilized sample valve. Like in 
small scale experiments described before, samples are used for OD600nm measurement, 
microscopy, cfu analysis (in independent duplicates) and for preparation of Western Blots 
samples, but also for Flow Cytometry analysis (see below). Expression is induced by injecting 
the chemical inducer (e.g. L-arabinose) at an OD600nm ≈0.75 via a septum. E-lysis is induced 
15-30min later by temperature increase to +42°C. Lysis is conducted after pO2 levels reach 
the plateau and flow cytometric analyses show complete lysis (≈120min). 
7.13.4 ONLINE MONITORING VIA FLOW CYTOMETRY 
To monitor the status of the bacterial culture and distinguish between live cells, dead intact 
cells and dead empty cells (BGs), flow cytometry is used. 
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Samples from the fermentation broth are diluted in 0.85% saline 103 to 104fold in order to 
keep count rates at roughly 1000sec-1. To 1ml diluted sample, 1µl each of two fluorescent 
dyes (DiBAC4(3) and RH414, both obtained from Anaspec, Fremont, CA, USA) are added.  
After vortexing, the sample is run through a CyFlow analyzer, with flow rates adjusted to 
keep the count rate at ≈1000sec-1. 
By excluding non-cellular background not stained by RH414 and combining the Forward 
Scatter Signal (FSC) and the Fluorescence Signal (FL1) of DiBAC4(3), three different areas can 
be defined: 
- Region 1 (R1), live intact cells: low FL1 signal (intact membrane potential), high FSC 
(opaque cells) 
- Region 2 (R2), dead intact cells: high FL1 signal (no membrane potential), high FSC 
(intact cells maintaining their opacity) 
- Region 3 (R3), dead lysed cells: high FL1 signal (no membrane potential), low FSC 
(BGs are more translucent than intact cells) 
This allows an “online” (approximately 10min after sample taking) observation of the 
bacterial culture, and more importantly, for the differentiation between lysis and killing 
because of e.g. foreign gene expression, which is not possible via cfu determination. 
7.13.5 HARVESTING 
After completed lysis, BGs are harvested via Tangential Flow Filtration (TFF) in a 0.2μm 
hollow fibre module at a temperature of 15°C, reducing the volume from 22l to 2l. 
7.13.6 KILLING 
To kill remaining, non-lysed cells, β-Propiolactone (BPL – obtained from Ferak, Berlin, 
Germany) is added to the 2l concentrate in two 0.0375% doses 30min apart. Inactivation is 
done while stirring at 42°C. 
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7.13.7 WASHING AND LYOPHILIZATION 
To remove medium and residual cytoplasmic content from the product, the broth is washed 
with a total of 5l of sterile dH2O by diafiltration, using a smaller 0.2μm hollow fibre module. 
During the non-steady state diafiltration, the volume is further reduced to 400ml, a 55fold 
reduction from the starting volume. 
The 400ml of BG suspension are aliquoted into weighted lyophilisation bottles, stored at -
20°C over night, followed by -80°C over night storage and are lyophilized in a Lyolab B 
machine for three days. Lyophilized BG bottles are weighted and the dry weight yield is 
calculated and labeled. BG bottles are stored at RT. 
7.13.8 STERILITY TESTING 
To test the sterility of the final product, about 10mg of lyophilisate are resuspended in 1.5ml 
LBv medium in triplicates. 
- 1ml of the suspension are used for pour plating with 20ml of hand-warm agar. 
- 100µl of the suspension are plated on a count agar plate 
- 200µl of the suspension are plated on a count agar plate 
- 100µl of the suspension are used to inoculate 5ml LBv and incubated overnight. 
o 100µl of this enrichment are plated on a count agar plate 
o 200µl of this enrichment are plated on a count agar plate 
- All plates are incubated at +36°C for at least 24h. 
7.14 CALCULATING LYSIS EFFICIENCY AND YIELD 
Lysis efficiency is calculated by comparing the highest cfu value with the lowest cfu value: 
                  
            
   
                
       
Particle yield per mg is calculated by multiplying the cfu per ml prior to lysis induction with 
the total volume of the fermentation process, divided by the total yield after harvesting: 
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To calculate the average amount of quantified antigen per BG, first the number of proteins 
per µg BG is calculated. To this end, the protein’s mass in kDa has to be converted to gram: 
     1.660538921         
Using this calculated mass per µg, the number of proteins per µg BG is calculated: 
        
  
       
               
 
   
               
 
Using the above calculated particle yield per mg, the amount of protein per particle (BG) can 
be derived: 
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8 APPENDIX 
8.1 IMMUNOCONTRACEPTION IN POSSUMS 
8.1.1 INTRODUCTION 
The brushtail possum (Trichosorus vulpecula) is a recent addition to the biosphere of New 
Zealand; it was introduced by humans to start a fur industry, but the lack of natural 
predators lead to a rapid and (for other species) disastrous proliferation (Montague, 2000). 
Possums harm trees and other plants, destroy bird’s habitats and are a vector of diseases 
affecting cattle and deer (National Science Strategy Committee for the Control of Possums 
and Bovine Tuberculosis., 2000). 
As a cost-effective, long-term and humane method to reduce possum numbers and their 
impact on the biosphere of New Zealand, the development of an immunocontraceptive to 
decrease possum fertility was suggested (Magiafoglou, et al., 2001). 
Several target molecules acting during early embryonic stages of the possum’s development 
were identified to be used for a BG derived immunocontraceptive (Walcher, et al., 2008). 
Among them is the Coat Protein 4 (CP4), a protein found in the shell coat of the possum’s 
egg, unique among marsupials and therefore an ideal candidate for immunocontraception 
(Selwood, 2000). CP4 is secreted by the oviduct and uterus, and plays an important role in 
late cleavage of blastocyte development, as well as in epithelial maintenance (Frankenberg, 
et al., 1998). 
8.1.2 GOALS 
Among several other immunocontraceptive target proteins, the CP4 of the possum’s egg was 
to be cloned into an expression vector system for the periplasmatic presentation, followed 
by E-mediated lysis to produce CP4-loaded BGs. 
While the Zona pellucida protein 2 C-terminal region (ZP2C) was successfully cloned and 
used for production of BGs, in previous studies in this laboratory CP4 was not successfully 
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cloned into the expression vector system pBGKB, due to an overwhelming amount of 
mutations (Schlacher, 2009). 
Since mutations were possibly already present in the original plasmids used to amplify the 
CP4 gene, it was decided to synthesize CP4 – in its E. coli-codon optimized form – de novo. 
The coding sequence as described at Genbank was used (Genbank accession number: 
EF121769.1), and synthesis was done by Microsynth (Microsynth, Balgach, Switzerland). 
The CP4opt gene was cloned into a standard vector by Microsynth. The CP4opt gene was 
transferred from this plasmid (pSlo1.0A-CP4opt) into pBGKB without the need for PCR 
amplification as shown in Figure 66. 
 
Figure 66: Cloning strategy to incorporate CP4opt into pBGBK, giving rise to pBGKB-CP4opt 
The resultant plasmid pBGKB-CP4opt has a size of 4937bp; upon induction with L-arabinose, 
a 39.8kDa protein in the form of GIII-CP4-Myc-PolyHis is expressed and exported to the 
periplasm. When the GIII export sequence is cleaved off, the resultant protein has a size of 
37.0kDa. 
Additionally, as a positive control to check both induction with L-Arabinose as well as the 
detection with Anti-Myc-Antibodies, pBAD-GIII-Calmodulin was used in an early experiment. 
This plasmid is available from Invitrogen (Invitrogen, 2008) and its features are detailed in 
Figure 67. 
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Figure 67: Schematic representation of plasmid pBAD-GIII-Calmodulin. Indicated are the ampicillin 
resistance cassette (Amp), the pBR322 origin of replication (pBR322 ori), the PBAD promoter (PBAD), the 
regulatory AraC protein (araC) and the GIII-Calmodulin-Myc-PolyHis fusion gene. 
The pBAD-GIII-Calmodulin has a size of 4556bp; upon induction with L-arabinose, a 21.3kDa 
protein in the form of GIII-Calmodulin-Myc-PolyHis is expressed and exported to the 
periplasm. When the GIII export sequence is cleaved off, the resultant protein has a size of 
19.2kDa. 
8.1.3 RESULTS 
8.1.3.1 CLONING pBGKB-CP4OPT 
Midipreps of E. coli C2988J (pBGKB) and of E. coli C2988J (pSlo1.0A-CP4opt) were used to 
perform this cloning; no PCR amplification was necessary. Instead, both vectors were used 
for a large scale digest with BglII and XbaI that ‘linearized’ pBGKB and excised CP4opt from 
pSlo1.0A-CP4opt. After three hours of digestion, the fragments were put on an agarose gel; 
correct sized bands were excised and eluted from the gel using the Gel Extraction Kit. An 
aliquot of purified DNA was put on an agarose gel (see Figure 68); the expected sizes of the 
fragments were 4005bp for the pBGKB fragment and 948bp for the CP4opt. 
Ligation was performed overnight; the ligation mixture was transformed into MOPS-
competent E. coli C2988J, which were then plated on LB+Kan agar plates. After overnight 
incubation at 36°C, plates showed good efficiency of transformation. Four clones were 
picked, inoculated overnight in LBv+Kan and miniprepped on the next day. 
Miniprep DNA of different clones was first digested with a single enzyme (not shown), then a 
correct-sized clone was further digested with a total of four different restriction enzymes to 
check for the characteristic, correct pattern of pBGKB-CP4opt, as seen in Figure 69. 
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Figure 68: Vectors pBGKB and purified CP4opt after 
double digestion with BglII and XbaI, and 
purification, on a 1% agarose gel. Correct-sized 
bands can be seen at 948bp (CP4opt) and 4005bp 
(linearized pBGKB). Marker: GeneRuler™ 1kb DNA 
Ladder (Fermentas) 
Figure 69: Digest of pBGKB-CP4opt clone A1 on a 1% 
agarose gel. Lane R1: pBGKB-CP4opt digested with 
HindIII, expected size: 4937bp; Lane R2: pBGKB-CP4opt 
digested with ApaI, expected size: 4937bp; Lane R3: 
pBGKB-CP4opt digested with PvuI, expected sizes: 
1865/3072bp; Lane R4: pBGKB-CP4opt digested with 
XhoI, expected sizes: 2279/2658bp. Marker: GeneRuler™ 
1kb DNA Ladder (Fermentas) 
Clone A1 of E. coli C2988J (pBGKB-CP4opt) was identified as correct by restriction digest 
pattern analysis and stored as a glycerol culture; no sequencing analysis was performed. The 
clone was used for a small scale Expression Experiment in E. coli C2988J and its midiprep 
DNA was used for transformation in E. coli NM522. 
8.1.3.2 SMALL-SCALE EXPRESSION EXPERIMENT 
In this small scale Expression Experiment, eight noseflasks were inoculated with overnight 
culture of six different E. coli C2988J (pBGKB-CP4opt) clones, one noseflask with E. coli 
C2988J (pSlo1.0A-CP4opt), and one noseflask with E. coli C2988J (pBAD-GIII-Calmodullin). 
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All noseflasks were grown at 36°C until an OD600nm≈0.3, when expression was induced by 
adding 0.2% L-Arabinose to pBGKB vectors and 5mM IPTG to pSlo1.0A-CP4opt (time point 
0min). OD600nm were measured and WB samples were collected throughout the experiment, 
but no cfu counts were analysed; the OD600nm over time are given in Figure 70. 
 
Figure 70: OD values over time during an Expression Experiment of E. coli C2988J (pSlo1.0A-CP4opt) 
(flask 1), six clones of E. coli C2988J (pBGKB-CP4opt) (flasks 2 – 7) and E. coli C2988J (pBAD-GIII-Calmodullin) 
(flask 8). L-Arabinose was added at time point 0min to flasks 2-8, and IPTG to flask 1. 
The induction of protein expression had no noticeable influence on OD600nm. 
Western Blot samples after 90min of protein expression were separated on a 4-12%-Bis-Tris-
Gel with MES buffer. The gel was blotted onto nitrocellulose, the nitrocellulose incubated 
with HRP-coupled-Anti-Myc-Antibodies and developed by chemiluminiscence and can be 
seen in Figure 71. Protein GIII-CP4opt-Myc-PolyHis was expected at a size of 39.8kDa, 
CP4opt-Myc-PolyHis at a size of 37.0kDa, GIII-Calmodulin-Myc-PolyHis at 21.3kDa and 
Calmodulin-Myc-PolyHis at a size of 19.2kDa. 
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Figure 71: Western Blot of E. coli C2988J (pBGKB-CP4opt) Expression Experiment, using Unstained 
Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 diluted 
HRP-coupled Anti-Myc-Antibodies and developed. Samples were taken 90min after expression induction. 
Very faintly, and at the correct position, the putative CP4 signal can be seen in samples C2-7 
after induction. Since CP4 is not Myc-tagged in sample C1, no detection was expected for 
pSlo1.0A-CP4opt samples. The positive control sample of pBAD-GIII-Calmodulin also shows a 
very faint sample at the expected size (GIII-Calmodulin-Myc-PolyHis at 21.3kDa and 
Calmodulin-Myc-PolyHis at a size of 19.2kDa). As also the positive control’s signals are very 
weak, better pictures can be expected from repeated blots and/or new batches of 
antibodies. 
8.1.3.3 SMALL-SCALE EXPRESSION/LYSIS EXPERIMENT 
A total of eight different clones of E. coli NM522 (pBGKB-CP4opt, pGLysivb) were tested. 
While lysis efficiency was >99.8% in all cases, the amount of CP4 detectable by Western Blot 
Analysis was very low and often hardly distinguishable from non-specific background signal. 
The small-scale Expression/Lysis Experiment of one clone (A8) that was later used for 
fermentation is shown below in Figure 72: 
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Figure 72: OD and cfu values over time during an Expression/Lysis Experiment of two different clones of 
E. coli NM522 (pBGKB-CP4opt, pGLysivb) and one clone of E. coli NM522 (pBGKB, pGLysivb). L-Arabinose was 
added at time point -60min; lysis was induced by shifting all four flasks to 42°C at time point 0min. 
Lysis efficiency is at 99.88%, regardless whether pBGKB-CP4opt or the empty backbone 
plasmid pBGKB is induced by 0.2% L-Arabinose addition. 
Western Blot samples after 60’ of protein expression and after 60min of lysis were separated 
on a 4-12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto nitrocellulose, the 
nitrocellulose incubated with HRP-coupled-Anti-Myc-Antibodies and developed by 
chemiluminiscence, as seen in Figure 73. Protein GIII-CP4opt-Myc-PolyHis was expected at a 
size of 39.8kDa, and protein CP4opt-Myc-PolyHis at a size of 37.0kDa. 
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Figure 73: Western Blot of E. coli NM522 (pBGKB-CP4opt, pGLysivb) Expression/Lysis experiment, using a 
sample from E. coli C2988J (pBGKB-CP4opt) Expression Experiment as a positive control (C7), and using 
Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with 
MES Running Buffer, the gel was blotted onto nitrocellulose. The nitrocellulose was incubated with 1:5000 
diluted HRP-coupled Anti-Myc-Antibodies and developed. Samples were taken 60min after expression 
induction, and again 60min after lysis induction. 
While CP4 can faintly be detected before lysis (C8), the signal drops further after lysis 
induction (F8) suggesting that the product is partially lost during E-lysis. Nevertheless, a 
fermentation was performed to see growth and expression behaviour in large scale. 
8.1.3.4 E. COLI NM522 (pBGKB-CP4OPT, pGLYSIVB) FERMENTATION 
After testing several clones of E. coli NM522 (pBGKB-CP4opt, pGLysivb) for differences in 
lysis efficiency and CP4 expression, working stocks of clone A8 of E. coli NM522 (pBGKB-
CP4opt, pGLysivb) were prepared. These were used to inoculate an overnight culture for 
fermentation. 
Fermentation was performed in a volume of 22l LBv pH 7.2, with antibiotics kanamycin and 
gentamicin added. In 30min intervals, samples were withdrawn to measure OD600nm, check 
bacterial viability via the microscope, prepare Western Blot samples and plate dilutions for 
cfu determination on count agar plates. No flow cytometry was performed for this 
fermentation because of malfunctioning equipment. 
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Protein expression was induced after 30min of growth at 35°C by adding 0.2% L-Arabinose; 
after 90min of expression, lysis was induced by temperature upshift of the culture to 42°C; 
OD600nm values and cfu counts over time are shown in Figure 74. 
 
Figure 74: OD and cfu values over time during fermentation in 22l of E. coli NM522 (pBGKB-CP4opt, 
pGLysivb). L-Arabinose was added at time point B (-90min); lysis was induced by increasing the temperature to 
42°C at time point E (0min). 
Both OD600nm and cfu increase from the time point of expression induction until lysis 
induction, but the cfu increase is only a little more than twofold in the 120min until lysis 
induction. After that, both values drop sharply (from 6.65*108cfu/ml at time point E to 
1.48*105cfu/ml at time point I – a lysis efficiency of 99.978%). 
Important fermentation parameters such as flow, stirring rate, temperature or pO2 are 
documented using the IRIS software and detailed below in Figure 75: 
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Figure 75: IRIS diagram documenting fermentation parameters like pH (regulated at 7.2), temperature 
(35°C during growth and expression, 42°C during lysis), flow rate, stirring rate, oxygen concentration and 
addition of anti-foam (used to counteract the foaming initiated by expulsion of cytoplasmic content during 
lysis). 
In the IRIS diagram, the oxygen curve is of particular interest, as the oxygen curve does not 
show the characteristic sharp drop upon lysis induction, but only a smaller drop followed by 
a stepwise increase and finally a typical shift up to the plateau. This final increase happens at 
about 60min, while normally it is seen already after 30min. 
Several other specifications as well as follow-up experiments of this particular fermentation 
are detailed below in Table 19: 
E. coli NM522 (pBGKB-Cp4opt, pGLyisvb) Bacterial Ghosts 
Pre-Culture 
Volume: 2l Additives: Gentamicin + Kanamycin 
Medium type: LBv Other: GJS80, 7 drops Antifoam (1:3) 
Date: 2009-07-01 Clone: c.8 (2009-05-20/WS 2009-06-24 FHO) 
Starting time: 09:35 Strain: E. coli NM522 
End time:  Plasmids: pGLysivb, pBGKB-CP4opt 
ON culture OD: 1.407/0.315 Recombinant Protein Expression: GIII-CP4opt-Myc-
PolyHis 
Inoc. Volume: 2l Expression Induction: L-Arabinose, 0.2% 
Medium: LBv Expression Induction Time Point: B 
Antibiotics: Gentamicin + Kanamycin Lysis Induction: 42°C 
Temperature: 35°C Lysis Induction Time Point: E 
Total Volume: ≈22l Killing: after harvest, 0.075% BPL (2*0.0375%) 
Acid: F.A.: 52 units Volume harvested: 20l 
Base: A.W.: 75 units Harvested by: TFF 
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antifoam A: 10 units OD separator flow: - 
Eivb blot: - Yield: 7480mg 
Recombinant blot: OK (by FHO) Particles/mg: 1.78 x 109 
BPL killing: Survivors (by AME) Sterility: OK (by EDZ) 
Microscopy: ok / some dead / some 
elongated 
Efficiency: 99.978% 
Table 19:  Fermentation data sheet of E. coli NM522 (pBGKB-CP4opt, pGLysivb) fermentation 
While colonies after ß-PL killing could be detected, PCR analysis of these colonies failed to 
detect the gentamicin resistance gene, suggesting a later contamination. Sterility tests of the 
freeze-dried lyophilisate indicate a sterile product. From a total of 20l fermentation volume, 
harvesting and lyophilisation yielded 7480mg of BGs dry weight. Calculating from a cfu count 
of 6.65*108/ml at the time point of lysis induction, and a harvested volume of 20l, the 
lyophilisate contains 1.78*109particles/mg. 
Western Blot samples taken throughout the fermentation process were separated on a 4-
12%-Bis-Tris-Gel with MES buffer. The gel was blotted onto nitrocellulose, the membrane 
incubated with HRP-coupled-Anti-Myc-Antibodies and developed by chemilumiscence; the 
protein GIII-CP4opt-Myc-PolyHis was expected at a size of 39.8kDa, while CP4opt-Myc-
PolyHis was expected at 37.0kDa. Several Western Blots of this fermentation were done 
because of the very low signal. Besides detection employing Anti-Myc-Antibodies, Anti-CP4-
Serum (not shown) and Anti-His-Antibodies were used, but all showed the same results of 
very low recombinant protein expression, as seen in Figure 76. 
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Figure 76: Western Blot of E. coli NM522 (pBGKB-CP4opt, pGLysivb) Fermentation and BGs, using 
Unstained Protein Molecular Weight Marker (Fermentas). Proteins were separated on a 4-12% Bis-Tris-Gel with 
MES Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted 
HRP-coupled Anti-His-Antibodies and developed. Samples after β-PL treatment are five-fold concentrated 
compared to samples taken during the fermentation process. Different concentrations of lyophilized BGs were 
also loaded onto the gel (2µg, 5µg, 20µg). As a positive control, a sample from a previous small scale 
experiment was used. 
While detection of CP4 after lysis is possible, it is only seen in highly concentrated samples 
(such as after ß-PL treatment), or high amounts of lyophilized BGs, indicating its low 
abundance. 
8.1.3.5 QUANTIFICATION OF CP4 IN E. COLI NM522 BGS 
In order to quantify the amount of recombinant CP4 per µg E. coli NM522 BG, the signals 
obtained from a serial dilution of BGs (Techfors Fermentation of E. coli NM522 (pBGKB-
CP4opt, pGLysivb), see 8.1.3.4) with known concentration and a serial dilution of positope 
(containing the Myc-epitope) with known concentration were compared on a Western Blot, 
as seen in Figure 77. 
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Figure 77: Western Blot of E. coli NM522 (pBGKB-CP4opt, pGLysivb) BGs and positope, using Unstained 
Protein Molecular Weight Marker (Fermentas). Samples were separated on a 4-12% Bis-Tris-Gel with MES 
Running Buffer, the gel was blotted onto nitrocellulose. Nitrocellulose was incubated with 1:5000 diluted HRP-
coupled Anti-Myc-Antibodies and developed. The amount of lyophilized BGs, as well as of positope per lane is 
indicated. As a negative control, lyophilized BGs from an E. coli NM522 (pGLysivb) Fermentation were used. 
The chemiluminiscence signals generated by HRP-coupled-Anti-Myc-Antibodies at the site of 
positope and CP4 bands were measured using the ChemidocXRS machine; with the standard 
curve provided by the positope, the amount of CP4 per µg BG could be calculated, as 
outlined in Figure 78: 
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Figure 78: Quantification curve for E. coli NM522 (pBGKB-CP4opt, pGLysivb) BGs. Signals generated by 
positope with known concentration are indicated by blue diamonds, the linear regression curve is shown in 
black. Signals generated by BG samples are indicated as detailed in the legend. 
The square of the correlation coefficient is R²=0.9842, an acceptable fit of the standard curve 
provided by the positope. Calculated on that basis, the amounts shown in Table 20 of CP4 
are found in BGs. 
Lane Amount of BGs Calc. Total Amount of CP4 Calc. Amount CP4/µg BG 
U1 100µg 62.64ng 0.63ng 
U2 40µg 54.85ng 1.37ng 
U3 20µg 28.38ng 1.42ng 
Table 20:  Calculating the average amount of CP4 per µg of E. coli NM522 BGs 
On average, one microgram of E. coli NM522 BGs contains 1.14 ± 0.44ng CP4. 
The molecular weight of CP4 of 37.0kDa translates into a mass of 6.14∙10-20g, therefore, one 
microgram of E. coli NM522 BGs contains 1.86∙1010 CP4 molecules. Assuming a particle count 
of 1.78∙106 BGs/µg, a single E. coli NM522 BG contains 1.04∙104 CP4 molecules. 
8.1.4 DISCUSSION 
In contrast to previous attempts (Schlacher, 2009), it was possible to clone the CP4opt gene 
into the periplasm anchoring backbone vector pBGKB. The plasmid pBGKB-CP4opt was 
checked for correct size by restriction digests, but not sequence analysed, since the CP4opt 
sequence itself was synthesized and sequenced prior to shipping by Microsynth. Expression 
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was determined to be very low in Expression Experiments. In Expression/Lysis Experiments, 
a slight decrease of CP4 after lysis induction, as seen e.g. in Figure 73, might hint at 
incomplete transport into the periplasm. However, no CP4 expression at all was observed in 
samples taken during fermentation process, only concentrated samples and lyophilized BGs 
were shown to contain traces of CP4. 
While the total amount of CP4 – calculated to be 1.14ng per µg BG – is comparatively low, 
this does not necessarily reflect its antigenicity or the strength of the induced immune 
response. On average, 10,000 CP4 molecules are present on a single BG, values that are well 
in the range of previous experiments (Champeimont, 2008). 
More than 7g of BGs displaying CP4 are available for shipping to New Zealand to assess their 
immunogenicity, and thereby the concept of using BGs for immunocontraception. 
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8.2 USED ABBREVIATIONS 
The abbreviations and symbols used during this work are given in Table 21: 
Abbreviation Meaning 
µg microgram 
µl microlitre 
aa amino acid 
AB antibody 
BG(s) Bacterial Ghost(s) 
bp base pair 
C. trachomatis Chlamydia trachomatis 
cfu colony forming unit 
CP4 Coat Protein 4 of Trichosorus vulpecula 
CP4opt 
DNA sequence of Coat Protein 4 of Trichosorus 
vulpecula, codon-optimized for E. coli 
Da 
Dalton, atomic mass unit 
1Da = 1.660538921∙10-30g 
dH2O deionised water 
DNA Deoxyribonucleic acid 
E. coli Escherichia coli 
fwd Forward 
g Gram 
g 
standard acceleration due to free fall, i.e. 
9.81m/s² 
hCG-ß-LTB 
human choriongonadotropin-ß fused to heat 
labile enterotoxin B 
HRP Horseradish Peroxidase 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
KD dissociation constant 
kb kilo base pair 
kDa kilo Dalton 
l litre 
LHRH Luteinizing Hormone Releasing Hormone 
LPS Lipopolysaccharide 
M Molar, i.e. mol/L 
MCS Multiple Cloning Site 
mg milligram 
min minute(s) 
ml millilitre 
ng nanogram 
nm nanometre 
nt nucleotide 
OD600nm Optical Density at 600nm 
ORF Open Reading Frame 
ori Origin of Replication 
PCR Polymerase Chain Reaction 
PPS Periplasmic Space 
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rev reverse 
rpm rounds per minute 
sec Second 
Tm Annealing Temperature 
WB Western Blot 
Table 21:  List of used abbreviations and their meanings 
8.3 SYMBOLS USED IN CLONING STRATEGIES 
The following symbols were used to denote genes, promoters, and other genetic elements in 
schemes showing cloning strategies: 
8.3.1 GENES 
 
Symbol Meaning 
 
GIII export sequence of Gene III protein from 
bacteriophage fd, followed by a Multiple Cloning 
Site, a Myc tag and a PolyHis Tag. 
 
Gene encoding the Thiol:disulfide interchange 
protein DsbC precursor protein for the export to the 
periplasm, followed by PolyHis tag, followed by an S-
Tag, followed by a Multiple Cloning Site and again a 
PolyHis Tag 
 
Kanamycin resistance cassette 
 
Ampicillin resistance cassette 
 
Gentamicin resistance cassette 
 
Gene AraC, encoding the repressor protein of the L-
arabinose operon of E. coli 
 
Gene encoding a mutated mobility protein 
 
Gene encoding the lysis gene E of bacteriophage 
ΦX174 fused to an in vivo-biotinylation sequence 
 
Thermosensitive allele of the λ phage repressor gene 
 
LacI gene, regulated by a mutated high expression 
lacI promoter 
 
Repressor of Primer gene, regulating the plasmids 
copy number 
 
Gene encoding the N-terminal part (323aa) of 
Maltose Binding Protein, which targets fused 
proteins to the PPS 
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Gene encoding the lacZα protein, allowing for Blue-
White-Screening of transformants 
 
Gene encoding the lysis protein L of the 
bacteriophage M2 for C-terminal anchoring in the 
Inner Membrane 
 
Gene encoding protein PorB from Chlamydia 
trachomatis 
 
Gene encoding Major Outer Membran Protein from 
Chlamydia trachomatis 
 
Gene encoding codon-optimized Coat Protein 4 from 
Trichosorus vulpecula 
 
Gene encoding Calmodulin 
Table 22:  Symbols used for genes in cloning strategies 
8.3.2 OTHER GENETIC ELEMENTS 
 
Symbol Meaning 
 
 
Promoter of the ara operon 
 
 
Terminator region of the E. coli rrnB gene 
 
 
Origin of Replication, taken from plasmid pBR322 
 
 
Promoter of the lac operon 
 
 
M13 intergenic region, Origin of Replication 
 
 
Promoter recognized by the T7 RNA polymerase 
 
 
Terminator region for the T7 RNA polymerase 
 
 
Origin of Replication of bacteriophage F1 
 
 
Origin of Replication of the pUC plasmid 
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Origin of Replication of the pMB1 plasmid 
 
Origin of Replication of the ColE1 plasmid 
Table 23: Symbols used for genetic elements other than ORFs in cloning strategies 
 
8.4 PLASMID OVERVIEW 
An overview of plasmids used in this work is given in Table 24. 
Plasmid Expression Marker Ori Size Reference Page 
pBGKB GIII-Myc-PolyHis Kan pBR322 4042bp (Schlacher, 
2009) 
23 
pBAD-GIII-
Calmodulin 
GIII-Calmodulin-
Myc-PolyHis 
Amp pBR322 4556bp (Invitrogen, 
2011) 
- 
pSlo1.0A-
Cp4opt 
lacZ-CP4opt-
lacZ 
Amp pUC 3908bp This Work 122 
pET40b DsbC-PolyHis-S-
Tag-PolyHis 
Kan pBR322 6190 (Novagen, 2011) - 
pKS-MOMP LacZ-MOMP-L* Amp ColE1 ≈4870bp (Eko, et al., 
2003) 
- 
pMAL-PorB MBP-PorB Amp pBR322 7767 Eko, pers. 
communication 
- 
pGLysivb Eivb Gent Rep 6201 (Haidinger, 
2001) 
175 
       
pET40b-PorB DsbC-PolyHis-S-
Tag-PorB-
PolyHis 
Kan pBR322 7123bp This Work 28 
pASK GIII-PolyHis-S-
Tag-PolyHis 
Kan pBR322 4142bp This Work 29 
pASK-PorB GIII-PolyHis-S-
Tag-PorB-Myc-
PolyHis 
Kan pBR322 5141bp This Work 30 
pBGKB-PorB GIII-PorB-Myc-
PolyHis 
Kan pBR322 4979bp This Work 26 
pBGKB-
MOMP 
GIII-MOMP-
Myc-PolyHis 
Kan pBR322 5147bp This Work 31 
pBGKB-
CP4opt 
GIII-CP4opt-
Myc-PolyHis 
Kan pBR322 4937bp This Work 122 
Table 24: Overview of plasmids and their origin used in this work. 
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